. , La région 5' non codante

R. Abreu, A. C. Mcbain, A. J. Simões, and M. , Plants as sources of new antimicrobials and resistance-modifying agents, Nat. Prod. Rep, vol.29, pp.1007-1021, 2012.

R. Aquino, C. Conti, F. De-simone, N. Orsi, C. Pizza et al., Antiviral activity of constituents of Tamus communis, J. Chemother. Florence Italy, vol.3, pp.305-309, 1991.

B. Bartosch and J. Dubuisson, Recent Advances in Hepatitis C Virus Cell Entry, vol.2, pp.692-709, 2010.

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1-E2 Envelope Protein Complexes, J. Exp. Med, vol.197, pp.633-642, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00133783

F. A. Behery, Z. E. Naeem, G. T. Maatooq, M. M. Amer, Z. Wen et al., Phenanthrenoids from Juncus acutus L., new natural lipopolysaccharide-inducible nitric oxide synthase inhibitors, Chem. Pharm. Bull. (Tokyo), vol.55, pp.1264-1266, 2007.

N. Calland, J. Dubuisson, Y. Rouillé, and K. Séron, Hepatitis C virus and natural compounds: a new antiviral approach? Viruses, vol.4, pp.2197-2217, 2012.

N. Calland, M. Sahuc, S. Belouzard, V. Pène, P. Bonnafous et al., Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02104507

D. Delgrange, A. Pillez, S. Castelain, L. Cocquerel, Y. Rouillé et al., Robust production of infectious viral particles in Huh7 cells by introducing mutations in hepatitis C virus structural proteins, J. Gen. Virol, vol.88, pp.2495-2503, 2007.

D. Greca, M. Fiorentino, A. Isidori, M. Lavorgna, M. Monaco et al., Phenanthrenoids from the wetland Juncus acutus, Phytochemistry, vol.60, pp.633-638, 2002.

D. Greca, M. Fiorentino, A. Mangoni, L. Molinaro, A. Monaco et al., 10-dihydrophenanthrene metabolites from Juncus effusus L, Tetrahedron Lett, vol.9, pp.5257-5260, 1992.

J. Dubuisson, H. H. Hsu, R. C. Cheung, H. B. Greenberg, D. G. Russell et al., Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses, J. Virol, vol.68, pp.6147-6160, 1994.

D. Egger, B. Wölk, R. Gosert, L. Bianchi, H. E. Blum et al., Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex, J. Virol, vol.76, pp.5974-5984, 2002.

A. I. El-shamy, A. F. Abdel-razek, and M. I. Nassar, Phytochemical review of Juncus L. genus (Fam. Juncaceae), Arab. J. Chem, vol.8, pp.614-623, 2015.

R. A. Fridell, D. Qiu, L. Valera, C. Wang, R. E. Rose et al., Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052, J. Virol, vol.85, pp.7312-7320, 2011.

S. Gibbons, Anti-staphylococcal plant natural products, Nat. Prod. Rep, vol.21, pp.263-277, 2004.

L. Goueslain, K. Alsaleh, P. Horellou, P. Roingeard, V. Descamps et al., Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication, J. Virol, vol.84, pp.773-787, 2010.

C. S. Graham and T. Swan, A path to eradication of hepatitis C in low-and middle-income countries, Antiviral Res, vol.119, pp.89-96, 2015.

B. Hajarizadeh, J. Grebely, and G. J. Dore, Epidemiology and natural history of HCV infection, Nat. Rev. Gastroenterol. Hepatol, vol.10, pp.553-562, 2013.

T. Kato, T. Date, M. Miyamoto, A. Furusaka, K. Tokushige et al., Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon, Gastroenterology, vol.125, pp.1808-1817, 2003.

A. Kovács, A. Vasas, and J. Hohmann, Natural phenanthrenes and their biological activity, Phytochemistry, vol.69, pp.1084-1110, 2008.

P. Krishnan, J. Beyer, N. Mistry, G. Koev, T. Reisch et al., Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A, vol.59, pp.979-987, 2015.

R. Ksouri, Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications, Crit Rev Biotechnol, vol.32, pp.289-326, 2012.
DOI : 10.3109/07388551.2011.630647

D. Lavanchy, Evolving epidemiology of hepatitis C virus, Clin. Microbiol. Infect, vol.17, pp.107-115, 2011.
DOI : 10.1111/j.1469-0691.2010.03432.x
URL : https://doi.org/10.1111/j.1469-0691.2010.03432.x

S. Lecot, S. Belouzard, J. Dubuisson, and Y. Rouillé, Bovine Viral Diarrhea Virus Entry Is Dependent on Clathrin-Mediated Endocytosis, J. Virol, vol.79, pp.10826-10829, 2005.
DOI : 10.1128/jvi.79.16.10826-10829.2005
URL : https://hal.archives-ouvertes.fr/hal-00105462

M. Levrero, Viral hepatitis and liver cancer: the case of hepatitis C, Oncogene, vol.25, pp.3834-3847, 2006.

T. J. Liang and M. G. Ghany, Current and Future Therapies for Hepatitis C Virus Infection, N. Engl. J. Med, vol.368, pp.1907-1917, 2013.

B. D. Lindenbach, H. Thiel, and C. M. Rice, Flaviviridae: the viruses and their replication, Fields Virology 5th Edition. David M. Knipe, pp.1101-1152, 2007.

J. P. Messina, I. Humphreys, A. Flaxman, A. Brown, G. S. Cooke et al., Global distribution and prevalence of hepatitis C virus genotypes, Hepatology, vol.61, pp.77-87, 2015.
DOI : 10.1002/hep.27259
URL : http://europepmc.org/articles/pmc4303918?pdf=render

Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki et al., The lipid droplet is an important organelle for hepatitis C virus production, Nat. Cell Biol, vol.9, pp.1089-1097, 2007.
DOI : 10.1038/ncb1631

D. Moradpour, M. J. Evans, R. Gosert, Z. Yuan, H. E. Blum et al., Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes, J. Virol, vol.78, pp.7400-7409, 2004.

H. Nakabayashi, K. Taketa, K. Miyano, T. Yamane, and J. Sato, Growth of Human Hepatoma Cell Lines with Differentiated Functions in Chemically Defined Medium, Cancer Res, vol.42, pp.3858-3863, 1982.

D. J. Newman and G. M. Cragg, Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010, J. Nat. Prod, vol.75, pp.311-335, 2012.

J. Pawlotsky, New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges, vol.146, pp.1176-1192, 2014.
DOI : 10.1053/j.gastro.2014.03.003

J. Pawlotsky, Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens, Gastroenterology, vol.151, pp.70-86, 2016.
DOI : 10.1053/j.gastro.2016.04.003

V. Pène, C. Hernandez, C. Vauloup-fellous, J. Garaud-aunis, and A. R. Rosenberg, Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment, J. Viral Hepat, vol.16, pp.705-715, 2009.

P. Podevin, A. Carpentier, V. Pène, L. Aoudjehane, M. Carrière et al., Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes, Gastroenterology, vol.139, pp.1355-1364, 2010.

S. J. Polyak, N. H. Oberlies, E. Pécheur, H. Dahari, P. Ferenci et al., Silymarin for hepatitis C virus infection, Antivir. Ther, vol.18, pp.141-147, 2013.

Y. Rouillé, F. Helle, D. Delgrange, P. Roingeard, C. Voisset et al., Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus, J. Virol, vol.80, pp.2832-2841, 2006.

H. Sarkar, M. Zerezghi, and J. Bhattacharyya, Dehydrojuncusol, a constituent of the roots of Juncus roemerianus, Phytochemistry, vol.27, pp.3006-3008, 1988.

C. Sarrazin, The importance of resistance to direct antiviral drugs in HCV infection in clinical practice, J. Hepatol, vol.64, pp.486-504, 2016.

A. W. Tarr, T. Khera, K. Hueging, J. Sheldon, E. Steinmann et al., Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design, Viruses, vol.7, pp.3995-4046, 2015.

Y. Wang, Y. Wang, H. Zhai, Y. Liao, B. Zhang et al., Phenanthrenes from Juncus effusus with anxiolytic and sedative activities, Nat. Prod. Res, vol.26, pp.1234-1239, 2012.

C. W. Wright, Halophyte-fodder species association may improve nutrient availability and biomass production of the Sabkha ecosystem, 2010.

C. Abdelly, Potential utilisation of halophytes for the rehabilitation and valorisation of salt-affected areas in Tunisia, 2006.

G. M. Abraham and L. M. Spooner, Sofosbuvir in the Treatment of Chronic Hepatitis C: New Dog, New Tricks, Clinical Infectious Diseases, vol.59, pp.411-415, 2014.

O. Adeyemo, H. Doi, K. Rajender-reddy, and D. E. Kaplan, Impact of oral silymarin on virus-and non-virus-specific T-cell responses in chronic hepatitis C infection, Journal of Viral Hepatitis, vol.20, pp.453-462, 2013.

F. Afaq, D. N. Syed, A. Malik, N. Hadi, S. Sarfaraz et al., Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVBmediated oxidative stress and apoptosis, J Invest Dermatol, vol.127, pp.222-232, 2007.

N. Afdhal, S. Zeuzem, P. Kwo, M. Chojkier, N. Gitlin et al., Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection, New England Journal of Medicine, vol.370, pp.1889-1898, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01690189

M. S. Afzal, N. U. Zaidi, J. Dubuisson, and Y. Rouille, Hepatitis C virus capsid protein and intracellular lipids interplay and its association with hepatic steatosis, Hepat Mon, vol.14, 2014.

A. Ahmed and E. Keeffe, Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference, Journal of gastroenterology and hepatology, vol.14, pp.12-18, 1999.

H. S. Aiyer, A. M. Warri, D. R. Woode, L. Hilakivi-clarke, and R. Clarke, Influence of Berry Polyphenols on Receptor Signaling and Cell-Death Pathways: Implications for Breast Cancer Prevention, Journal of Agricultural and Food Chemistry, vol.60, pp.5693-5708, 2012.

D. Akazawa, M. Moriyama, H. Yokokawa, N. Omi, N. Watanabe et al., Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice, Gastroenterology, vol.145, pp.447-455, 2013.

, Environ Pollut, vol.142, pp.151-159

C. M. Almeida, A. P. Mucha, and M. T. Vasconcelos, The role of a salt marsh plant on trace metal bioavailability in sediments. Estimation by different chemical approaches, Environ Sci Pollut Res Int, vol.12, pp.271-277, 2005.

C. M. Almeida, A. P. Mucha, and M. T. Vasconcelos, Influence of the sea rush Juncus maritimus on metal concentration and speciation in estuarine sediment colonized by the plant, Environ Sci Technol, vol.38, pp.3112-3118, 2004.

L. Alric and D. Bonnet, Grazoprevir + elbasvir for the treatment of hepatitis C virus infection, Expert Opin Pharmacother, vol.17, pp.735-742, 2016.

L. Alric, M. Fort, J. Izopet, J. P. Vinel, J. P. Charlet et al., Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection, Gastroenterology, vol.113, pp.1675-1681, 1997.

K. Alsaleh, P. Delavalle, A. Pillez, G. Duverlie, V. Descamps et al., Identification of basic amino acids at the Nterminal end of the core protein that are crucial for hepatitis C virus infectivity, J Virol, vol.84, pp.12515-12528, 2010.

H. J. Alter, P. V. Holland, R. H. Purcell, J. J. Lander, S. M. Feinstone et al., Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors, Ann Intern Med, vol.77, pp.691-699, 1972.

M. J. Alter, D. Kruszon-moran, O. V. Nainan, G. M. Mcquillan, F. Gao et al., The prevalence of hepatitis C virus infection in the United States, New England journal of medicine, vol.341, pp.556-562, 1988.

H. S. Althagafy, T. N. Graf, A. A. Sy-cordero, B. T. Gufford, M. F. Paine et al., Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle, Bioorganic & Medicinal Chemistry, vol.21, pp.3919-3926, 2013.

L. Alvarez-lajonchere, N. H. Shoukry, B. Gra, Y. Amador-canizares, F. Helle et al., Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, J Viral Hepat, vol.16, pp.156-167, 2009.

K. Andrae-marobela, F. W. Ghislain, H. Okatch, and R. R. Majinda, Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents, Current Drug Metabolism, vol.14, pp.392-413, 2013.

L. Bachmetov, M. Gal-tanamy, A. Shapira, M. Vorobeychik, T. Giterman-galam et al., Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity: Quercetin suppresses HCV through inhibition of NS3, New England Journal of Medicine, vol.19, pp.1207-1217, 2011.

D. Bagchi, C. K. Sen, S. D. Ray, D. K. Das, M. Bagchi et al., Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523-524, Expert Rev Anti Infect Ther, vol.14, pp.57-80, 2003.

M. R. Bailony, R. Scherzer, G. Huhn, M. W. Plankey, M. G. Peters et al., Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography, J Infect Dis, vol.208, pp.1776-1783, 2013.

A. Balagopal, D. L. Thomas, and C. L. Thio, IL28B and the control of hepatitis C virus infection, Gastroenterology, vol.139, pp.1865-1876, 2010.

M. Bamber, A. K. Murray, I. V. Weller, A. Morelli, P. J. Scheuer et al., Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis, J Clin Pathol, vol.34, pp.1175-1180, 1981.

D. Bankwitz, G. Vieyres, K. Hueging, J. Bitzegeio, M. Doepke et al., Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins, J Virol, vol.88, pp.12644-12655, 2014.

G. Barba, F. Harper, T. Harada, M. Kohara, S. Goulinet et al., Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets, Proceedings of the National Academy of Sciences, vol.94, pp.1200-1205, 1997.
DOI : 10.1073/pnas.94.4.1200
URL : http://www.pnas.org/content/94/4/1200.full.pdf

E. Barnes, A. Folgori, S. Capone, L. Swadling, S. Aston et al., Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man, Sci Transl Med, vol.4, pp.115-116, 2012.
DOI : 10.1126/scitranslmed.3003155
URL : http://europepmc.org/articles/pmc3627207?pdf=render

R. Bartenschlager, Hepatitis C Virus: From Molecular Virology to Antiviral Therapy, Current Topics in Microbiology and Immunology, 2013.

R. Bartenschlager, F. Cosset, and V. Lohmann, Hepatitis C virus replication cycle, J Hepatol, vol.53, pp.583-585, 2010.
DOI : 10.1016/j.jhep.2010.04.015
URL : https://doi.org/10.1016/j.jhep.2010.04.015

R. Bartenschlager, V. Lohmann, and F. Penin, The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection, Nature Reviews Microbiology, vol.11, pp.482-496, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00972320

R. Bartenschlager, F. Penin, V. Lohmann, and P. André, Assembly of infectious hepatitis C virus particles, Trends in Microbiology, vol.19, pp.95-103, 2011.

H. Barth, C. Schafer, M. I. Adah, F. Zhang, R. J. Linhardt et al., Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate, J Biol Chem, vol.278, pp.41003-41012, 2003.
DOI : 10.1074/jbc.m302267200
URL : http://www.jbc.org/content/278/42/41003.full.pdf

H. Barth, E. K. Schnober, F. Zhang, R. J. Linhardt, E. Depla et al., Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction, Journal of Virology, vol.80, pp.10579-10590, 2006.

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudoparticles Containing Functional E1-E2 Envelope Protein Complexes, Journal of Experimental Medicine, vol.197, pp.633-642, 2003.
DOI : 10.1084/jem.20021756
URL : https://hal.archives-ouvertes.fr/inserm-00133783

B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson et al., Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor, Journal of Biological Chemistry, vol.278, 2003.

R. Bataller and D. A. Brenner, Liver fibrosis, Journal of Clinical Investigation, vol.115, pp.209-218, 2005.

E. Beaumont, R. Patient, C. Hourioux, I. Dimier-poisson, and P. Roingeard, Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly 217 neutralizing antibodies and constitute a potential bivalent prophylactic vaccine, Hepatology, vol.57, pp.1303-1313, 2013.
DOI : 10.1002/hep.26132
URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.26132

N. Beglova and S. C. Blacklow, The LDL receptor: how acid pulls the trigger, Trends in Biochemical Sciences, vol.30, pp.309-317, 2005.
DOI : 10.1016/j.tibs.2005.03.007

F. A. Behery, Z. M. Naeem, G. T. Maatooq, M. M. Amer, and A. F. Ahmed, A novel antioxidant phenanthrenoid dimer from Juncus acutus L, Natural Product Research, vol.27, pp.155-163, 2013.
DOI : 10.1080/14786419.2012.662759

F. A. Behery, Z. E. Naeem, G. T. Maatooq, M. M. Amer, Z. Wen et al., Phenanthrenoids from Juncus acutus L., new natural lipopolysaccharide-inducible nitric oxide synthase inhibitors, Chem Pharm Bull (Tokyo), vol.55, pp.1264-1266, 2007.

S. Behrens, L. Tomei, and R. De-francesco, Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus, The EMBO journal, vol.15, p.12, 1996.

S. Beinhardt, S. Rasoul-rockenschaub, T. M. Scherzer, and P. Ferenci, Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C, J Hepatol, vol.54, pp.591-593, 2011.
DOI : 10.1016/j.jhep.2010.09.009
URL : https://doi.org/10.1016/j.jhep.2010.09.009

I. Benedicto, F. Molina-jiménez, O. Barreiro, A. Maldonado-rodríguez, J. Prieto et al., Hepatitis C virus envelope components alter localization of hepatocyte tight junctionassociated proteins and promote occludin retention in the endoplasmic reticulum, Hepatology, vol.48, pp.1044-1053, 2008.

I. Benedicto, F. Molina-jimenez, B. Bartosch, F. Cosset, D. Lavillette et al., The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection, J Virol, vol.83, pp.8012-8020, 2009.

Y. Benhamou, M. Bochet, V. Di-martino, F. Charlotte, F. Azria et al., Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients, Hepatology, vol.30, pp.1054-1058, 1999.
DOI : 10.1002/hep.510300409

L. Benitez, C. De-mendoza, Y. Berdichevsky, R. Zemel, L. Bachmatov et al., A novel high throughput screening assay for HCV NS3 serine protease inhibitors, J Virol Methods, vol.17, pp.245-255, 2003.

M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim et al., Antiviral Res, vol.100, pp.215-219

E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson et al., Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, pp.6964-6972, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00105504

K. J. Blight, J. A. Mckeating, and C. M. Rice, Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication, Journal of Virology, vol.76, pp.13001-13014, 2002.

B. S. Blumberg, H. J. Alter, and S. Visnich, A "new" antigen in leukemia sera, Jama, vol.191, pp.541-546, 1965.

H. J. Boermans, D. H. Percy, T. Stirtzinger, and B. A. Croy, Engraftment of severe combined immune deficient/beige mice with bovine foetal lymphoid tissues, Vet Immunol Immunopathol, vol.34, pp.273-289, 1992.

S. Boni, J. Lavergne, S. Boulant, and A. Cahour, Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA, Journal of Biological Chemistry, vol.280, pp.17737-17748, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00314209

P. Bonnafous, M. Perrault, O. Le-bihan, B. Bartosch, D. Lavillette et al., Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads, Journal of General Virology, vol.91, 2010.

M. Boscaiu, C. Lull, J. Llinares, O. Vicente, and H. Boira, Proline as a biochemical marker in relation to the ecology of two halophytic Juncus species, Journal of Plant Ecology, vol.6, pp.177-186, 2013.

S. Boulant, Structural Determinants That Target the Hepatitis C Virus Core Protein to Lipid Droplets, Journal of Biological Chemistry, vol.281, pp.22236-22247, 2006.
DOI : 10.1074/jbc.m601031200
URL : https://hal.archives-ouvertes.fr/hal-00313671

S. Boulant, C. Vanbelle, C. Ebel, F. Penin, and J. Lavergne, Hepatitis C Virus Core Protein Is a Dimeric Alpha-Helical Protein Exhibiting Membrane Protein Features, Journal of Virology, vol.79, pp.11353-11365, 2005.
DOI : 10.1128/jvi.79.17.11353-11365.2005
URL : https://hal.archives-ouvertes.fr/hal-00313681

S. D. Boyd, L. Tracy, T. E. Komatsu, P. R. Harrington, P. Viswanathan et al., US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection, Clin Drug Investig, 2017.
DOI : 10.1007/s40261-017-0492-5

V. Brass, J. M. Berke, R. Montserret, H. E. Blum, F. Penin et al., Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex, Proc Natl Acad Sci U S A, vol.105, pp.14545-14550, 2008.

V. Brass, R. Gosert, and D. Moradpour, Investigation of the hepatitis C virus replication complex, Methods Mol Biol, vol.510, pp.195-209, 2009.

M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu et al., CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes, Journal of Virology, vol.82, pp.8316-8329, 2008.

S. Brillanti, J. Garson, M. Foli, . Whitby, R. Deaville et al., A Pilot Study of Combination Therapy With Ribavirin Interferon Alfa for Interferon Alfa-Resistant Chronic Hepatitis C, 1994.

C. L. Brimacombe, J. Grove, L. W. Meredith, K. Hu, A. J. Syder et al., Neutralizing Antibody-Resistant Hepatitis C Virus Cell-toCell Transmission, Journal of Virology, vol.85, pp.596-605, 2011.
DOI : 10.1128/jvi.01592-10
URL : https://jvi.asm.org/content/85/1/596.full.pdf

E. A. Brown, H. Zhang, L. Ping, and S. M. Lemon, Secondary structure of the 5? nontranslated regions of hepatitis C virus and pestivirus genomic RNAs, Nucleic acids research, vol.20, pp.5041-5045, 1992.

M. D. Brown, Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer, Altern Med Rev, vol.4, pp.360-370, 1999.

R. C. Brown, A. H. Lockwood, and B. R. Sonawane, Neurodegenerative Diseases: An Overview of Environmental Risk Factors, Environmental Health Perspectives, vol.113, pp.1250-1256, 2005.

P. Bruggmann, T. Berg, A. L. Ovrehus, C. Moreno, C. E. Brandao-mello et al., J Viral Hepat, vol.21, pp.5-33, 2014.

N. Callens, Y. Ciczora, B. Bartosch, N. Vu-dac, F. Cosset et al., Basic Residues in Hypervariable Region 1 of Hepatitis C Virus Envelope Glycoprotein E2 Contribute to Virus Entry, Journal of Virology, vol.79, pp.15331-15341, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00313676

M. Cao, Y. Zhang, X. Li, Z. Peng, J. Jiang et al., Cyclohexane-fused octahydroquinolizine alkaloids from Myrioneuron faberi with activity against hepatitis C virus, J Org Chem, vol.79, pp.7945-7950, 2014.
DOI : 10.1021/jo501076x

B. M. Carneiro, M. N. Batista, A. C. Braga, M. L. Nogueira, and P. Rahal, The green tea molecule EGCG inhibits Zika virus entry, Virology, vol.496, pp.215-218, 2016.
DOI : 10.1016/j.virol.2016.06.012
URL : https://repositorio.unesp.br/bitstream/11449/178090/1/2-s2.0-84975527551.pdf

S. Carrere-kremer, C. Montpellier-pala, L. Cocquerel, C. Wychowski, F. Penin et al., Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus, Journal of Virology, vol.76, pp.3720-3730, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00313704

S. Castelain, V. Descamps, V. Thibault, C. François, D. Bonte et al., TaqMan amplification system with an internal positive control for HCV RNA quantitation, Journal of Clinical Virology, vol.31, pp.227-234, 2004.
DOI : 10.1016/j.jcv.2004.03.009

R. Castro, S. Pereira, A. Lima, S. Corticeiro, M. Valega et al., Accumulation, distribution and cellular partitioning of mercury in several halophytes of a contaminated salt marsh, Chemosphere, vol.76, pp.1348-1355, 2009.

M. T. Catanese, H. Ansuini, R. Graziani, T. Huby, M. Moreau et al., Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants, Journal of Virology, vol.84, pp.34-43, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00580589

M. T. Catanese, K. Uryu, M. Kopp, T. J. Edwards, L. Andrus et al., Ultrastructural analysis of hepatitis C virus particles, Proceedings of the National Academy of Sciences, vol.110, pp.9505-9510, 2013.

, Center for History and New Media, n.d. Guide rapide pour débuter

L. Cesoniene, I. Jasutiene, and A. Sarkinas, Phenolics and anthocyanins in berries of European cranberry and their antimicrobial activity, Medicina (Kaunas), vol.45, pp.992-999, 2009.

E. B. Chahine, A. J. Sucher, and B. A. Hemstreet, Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C, Ann Pharmacother, 2016.

, Res Clin Gastroenterol, vol.26, pp.381-389

Y. Chin, M. J. Balunas, H. B. Chai, and A. D. Kinghorn, Drug discovery from natural sources, The AAPS journal, vol.8, pp.239-253, 2006.

K. H. Chiow, M. C. Phoon, T. Putti, B. K. Tan, and V. T. Chow, Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection, Asian Pacific Journal of Tropical Medicine, vol.9, pp.1-7, 2016.

Q. L. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien et al., Vaccination of chimpanzees against infection by the hepatitis C virus, Proc Natl Acad Sci U S A, vol.91, pp.1294-1298, 1994.

Q. L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley et al., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, vol.244, pp.359-362, 1989.

H. S. Chow, Y. Cai, I. A. Hakim, J. A. Crowell, F. Shahi et al., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clin Cancer Res, vol.9, pp.3312-3319, 2003.

A. Chowdhury, J. Sarkar, T. Chakraborti, P. K. Pramanik, and S. Chakraborti, Protective role of epigallocatechin-3-gallate in health and disease: A perspective, 2016.

, Biomedicine & Pharmacotherapy, vol.78, pp.50-59

K. O. Chu, C. C. Wang, C. Y. Chu, K. P. Chan, M. S. Rogers et al., Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats, J Pharm Sci, vol.95, pp.1372-1381, 2006.

J. E. Chung, S. Tan, S. J. Gao, N. Yongvongsoontorn, S. H. Kim et al., Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy, Nature Nanotechnology, vol.9, pp.907-912, 2014.

S. Ciesek, T. Von-hahn, C. C. Colpitts, L. M. Schang, M. Friesland et al., The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry, Hepatology, vol.54, pp.1947-1955, 2011.

S. Ciesek, S. Westhaus, M. Wicht, I. Wappler, S. Henschen et al., Impact of intra-and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles, J Virol, vol.85, pp.7613-7621, 2011.

A. Cisowska, D. Wojnicz, and A. B. Hendrich, Anthocyanins as antimicrobial agents of natural plant origin, Nat Prod Commun, vol.6, pp.149-156, 2011.

D. Clarke, S. Griffin, L. Beales, C. S. Gelais, S. Burgess et al., Evidence for the Formation of a Heptameric Ion Channel Complex by the Hepatitis C Virus P7 Protein in Vitro, Journal of Biological Chemistry, vol.281, pp.37057-37068, 2006.

D. F. Cleary, V. Oliveira, N. C. Gomes, A. Pereira, I. Henriques et al., Impact of sampling depth and plant species on local environmental conditions, microbiological parameters and bacterial composition in a mercury contaminated salt marsh, Mar Pollut Bull, vol.64, pp.263-271, 2012.

S. Clichici, D. Olteanu, A. Filip, A. Nagy, A. Oros et al., Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis, J Med Food, vol.19, pp.789-797, 2016.

L. Cocquerel, A. Op-de-beeck, M. Lambot, J. Roussel, D. Delgrange et al., Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins, EMBO J, vol.21, pp.2893-2902, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00313702

L. Cocquerel, C. Wychowski, F. Minner, F. Penin, and J. Dubuisson, Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins, Journal of virology, vol.74, pp.3623-3633, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00313712

C. Colin, D. Lanoir, S. Touzet, L. Meyaud-kraemer, F. Bailly et al., Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature, J Viral Hepat, vol.8, pp.87-95, 2001.

K. E. Coller, K. L. Berger, N. S. Heaton, J. D. Cooper, R. Yoon et al., RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis, PLoS Pathogens, vol.5, 2009.

P. Colombatto, M. R. Brunetto, A. M. Maina, V. Romagnoli, P. Almasio et al., HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNalpha2a and Ribavirin: a randomized controlled trial, J Viral Hepat, vol.21, pp.458-465, 2014.

C. C. Colpitts and L. M. Schang, A Small Molecule Inhibits Virion Attachment to Heparan Sulfate-or Sialic Acid-Containing Glycans, Journal of Virology, vol.88, pp.7806-7817, 2014.

C. C. Colpitts, A. V. Ustinov, R. F. Epand, R. M. Epand, V. A. Korshun et al., 5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses, J Virol, vol.87, pp.3640-3654, 2013.

E. G. Cormier, R. J. Durso, F. Tsamis, L. Boussemart, C. Manix et al., L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus, Proceedings of the National Academy of Sciences of the United States of America, vol.101, pp.14067-14072, 2004.

E. G. Cormier, F. Tsamis, F. Kajumo, R. J. Durso, J. P. Gardner et al., CD81 is an entry coreceptor for hepatitis C virus, Proceedings of the National Academy of Sciences of the United States of America, vol.101, pp.7270-7274, 2004.

N. A. Counihan, S. M. Rawlinson, and B. D. Lindenbach, Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly, PLoS Pathogens, vol.7, 2011.

M. N. Couto, M. C. Basto, and M. T. Vasconcelos, Suitability of different salt marsh plants for petroleum hydrocarbons remediation, Chemosphere, vol.84, pp.1052-1057, 2011.

A. L. Cox, D. M. Netski, T. Mosbruger, S. G. Sherman, S. Strathdee et al., Prospective evaluation of community-acquired acute-phase hepatitis C virus infection, Clinical Infectious Diseases, vol.40, pp.951-958, 2005.

G. Cristofari, R. Ivanyi-nagy, C. Gabus, S. Boulant, J. Lavergne et al., The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro, Nucleic Acids Res, vol.32, pp.2623-2631, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00313688

Y. Cui, Y. J. Oh, J. Lim, M. Youn, I. Lee et al., AFM study of the differential inhibitory effects of the green tea polyphenol (?)epigallocatechin-3-gallate (EGCG) against Gram-positive and Gram-negative bacteria, Food Microbiology, vol.29, pp.80-87, 2012.

L. Cuypers, J. Snoeck, L. Kerremans, P. Libin, R. Crabbe et al., HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025HCV-203 phase II clinical trial, Infect Genet Evol, vol.44, pp.169-181, 2016.

C. Czank, A. Cassidy, Q. Zhang, D. J. Morrison, T. Preston et al., Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study, Am J Clin Nutr, vol.97, pp.995-1003, 2013.

J. L. Dienstag, Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features, Gastroenterology, vol.85, pp.439-462, 1983.

A. M. Domitrovich, K. W. Diebel, N. Ali, S. Sarker, and A. Siddiqui, Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication, Virology, vol.335, pp.72-86, 2005.

M. Dorner, J. A. Horwitz, B. M. Donovan, R. N. Labitt, W. C. Budell et al., Completion of the entire hepatitis C virus life cycle in genetically humanized mice, Nature, vol.501, pp.237-241, 2013.

M. Dorner, J. A. Horwitz, J. B. Robbins, W. T. Barry, Q. Feng et al., A genetically humanized mouse model for hepatitis C virus infection, Nature, vol.474, pp.208-211, 2011.

F. Douam, V. L. Dao-thi, G. Maurin, J. Fresquet, D. Mompelat et al., Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry, Hepatology, vol.59, pp.776-788, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00965121

D. Drane, E. Maraskovsky, R. Gibson, S. Mitchell, M. Barnden et al., Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers, Hum Vaccin, vol.5, pp.151-157, 2009.

D. Souza, R. Sabin, C. A. Foster, and G. R. , Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral Therapy, The American Journal of Gastroenterology, vol.100, pp.1509-1515, 2005.

G. Du, Z. Zhang, X. Wen, C. Yu, T. Calway et al., Epigalloctechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea, Nutrients, vol.4, pp.1679-1691, 2012.

J. Dubuisson, H. H. Hsu, R. C. Cheung, H. B. Greenberg, D. G. Russell et al., Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses, Journal of Virology, vol.68, pp.6147-6160, 1994.

J. Dubuisson and C. M. Rice, Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin, J Virol, vol.70, pp.778-786, 1996.

S. Duffy, L. A. Shackelton, and E. C. Holmes, Rates of evolutionary change in viruses: patterns and determinants, Nat Rev Genet, vol.9, pp.267-276, 2008.

R. Trial, JAMA, vol.308, p.274

H. Fukazawa, T. Suzuki, T. Wakita, and Y. Murakami, A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus, Biol Pharm Bull, vol.35, pp.1320-1327, 2012.

M. Furuse and S. Tsukita, Claudins in occluding junctions of humans and flies, Trends in Cell Biology, vol.16, pp.181-188, 2006.

J. Cangialosi, A. Du-chene, I. Legrand, R. Mangeot, I. Lavillette et al., A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques, Sci Transl Med, vol.3, 2011.

P. Gastaminza, G. Cheng, S. Wieland, J. Zhong, W. Liao et al., Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion, Journal of Virology, vol.82, pp.2120-2129, 2008.

D. Ge, J. Fellay, A. J. Thompson, J. S. Simon, K. V. Shianna et al., Genetic variation in IL28B predicts hepatitis C treatmentinduced viral clearance, Nature, vol.461, pp.399-401, 2009.

I. Gentile, E. Zappulo, A. R. Buonomo, A. E. Maraolo, and G. Borgia, Beclabuvir for the treatment of hepatitis C, Expert Opin Investig Drugs, vol.24, pp.1111-1121, 2015.

R. Gil, I. Bautista, M. Boscaiu, A. Lidon, S. Wankhade et al., Responses of five Mediterranean halophytes to seasonal changes in environmental conditions, AoB PLANTS, vol.6, pp.49-049, 2014.

G. Gitnick, Hepatitis C: controversies, strategies and challenges, European Journal of Surgery, vol.164, pp.65-70, 1998.

D. J. Gocke, A prospective study of posttransfusion hepatitis. The role of Australia Antigen, JAMA, vol.219, pp.1165-1170, 1972.

J. Goldwasser, P. Y. Cohen, W. Lin, D. Kitsberg, P. Balaguer et al., Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPARmediated mechanism, Journal of Hepatology, vol.55, pp.963-971, 2011.

M. Gomez-rubio, J. C. Porres, I. Castillo, J. A. Quiroga, A. Moreno et al., Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group, J Hepatol, vol.11, issue.1, pp.63-67, 1990.

O. Gonzalez, V. Fontanes, S. Raychaudhuri, R. Loo, J. Loo et al., The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production, Hepatology, vol.50, pp.1756-1764, 2009.

R. Gonzalez-barrio, G. Borges, W. Mullen, and A. Crozier, Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy, J Agric Food Chem, vol.58, pp.3933-3939, 2010.

F. Gonzalez-candelas, F. X. López-labrador, and M. A. Bracho, Recombination in Hepatitis C Virus, Viruses, vol.3, 2006.

R. Gosert, D. Egger, V. Lohmann, R. Bartenschlager, H. E. Blum et al., Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons, Journal of Virology, vol.77, pp.5487-5492, 2003.

J. M. Gottwein, T. B. Jensen, C. K. Mathiesen, P. Meuleman, S. B. Serre et al., Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 CoreNonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A, Journal of Virology, vol.85, pp.8913-8928, 2011.

L. Goueslain, K. Alsaleh, P. Horellou, P. Roingeard, V. Descamps et al., Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication, Journal of Virology, vol.84, pp.773-787, 2010.

J. Gouttenoire, V. Castet, R. Montserret, N. Arora, V. Raussens et al., Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B, Journal of Virology, vol.83, pp.6257-6268, 2009.

J. Gouttenoire, R. Montserret, A. Kennel, F. Penin, and D. Moradpour, An Amphipathic-Helix at the C Terminus of Hepatitis C Virus Nonstructural Protein 4B Mediates Membrane Association, Journal of Virology, vol.83, pp.11378-11384, 2009.

J. Gouttenoire, F. Penin, and D. Moradpour, Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory, Reviews in Medical Virology, vol.20, pp.117-129, 2010.

J. Gouttenoire, P. Roingeard, F. Penin, and D. Moradpour, Amphipathic alphahelix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B, J Virol, vol.84, pp.12529-12537, 2010.

H. N. Graham, Green tea composition, consumption, and polyphenol chemistry, Prev Med, vol.21, pp.334-350, 1992.

J. Grebely, K. Page, R. Sacks-davis, M. S. Loeff, T. M. Rice et al., The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection, Hepatology, vol.59, pp.109-120, 2014.

N. H. Grüner, T. J. Gerlach, M. Jung, H. M. Diepolder, C. A. Schirren et al., Characterization of Casein Kinase II as a Protein Kinase Responsible for Stimulation of HIV-1 Protease in Vitro, Biochemical and Biophysical Research Communications, vol.275, pp.434-439

X. Hanoulle, A. Badillo, J. Wieruszeski, D. Verdegem, I. Landrieu et al., Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B, Journal of Biological Chemistry, vol.284, pp.13589-13601, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00373457

X. Hanoulle, D. Verdegem, A. Badillo, J. Wieruszeski, F. Penin et al., Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded, Biochemical and Biophysical Research Communications, vol.381, pp.634-638, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00373459

S. Harada, E. Haneda, T. Maekawa, Y. Morikawa, S. Funayama et al., Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro, Biol Pharm Bull, vol.22, pp.1122-1126, 1999.

J. B. Harborne and C. A. Williams, Advances in flavonoid research since 1992, Phytochemistry, vol.55, pp.481-504, 2000.

H. J. Harris, M. J. Farquhar, C. J. Mee, C. Davis, G. M. Reynolds et al., CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry, J Virol, vol.82, pp.5007-5020, 2008.

P. Hartjen, S. Frerk, I. Hauber, V. Matzat, A. Thomssen et al., Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG, AIDS research and therapy, vol.9, p.1, 2012.

I. Hauber, H. Hohenberg, B. Holstermann, W. Hunstein, and J. Hauber, The main green tea polyphenol epigallocatechin-3-gallate counteracts semenmediated enhancement of HIV infection, Proceedings of the National Academy of Sciences, vol.106, pp.9033-9038, 2009.

R. L. Hawke, S. J. Schrieber, T. A. Soule, Z. Wen, P. C. Smith et al., Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C, The Journal of Clinical Pharmacology, vol.50, pp.434-449, 2010.

G. H. Haydon, L. M. Jarvis, C. S. Blair, P. Simmonds, D. J. Harrison et al., Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection, Gut, vol.42, pp.570-575, 1998.

J. He and M. M. Giusti, Anthocyanins: natural colorants with health-promoting, 2010.

J. Hwang, L. Huang, D. G. Cordek, R. Vaughan, S. L. Reynolds et al., Hepatitis C Virus Nonstructural Protein 5A: Biochemical Characterization of a Novel Structural Class of RNA-Binding Proteins, Journal of Virology, vol.84, pp.12480-12491, 2010.

P. P. Ip, H. W. Nijman, J. Wilschut, and T. Daemen, Therapeutic vaccination against chronic hepatitis C virus infection, Antiviral Research, vol.96, pp.36-50, 2012.

C. E. Isaacs, G. Y. Wen, W. Xu, J. H. Jia, L. Rohan et al., Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus, Antimicrobial Agents and Chemotherapy, vol.52, pp.962-970, 2008.

C. E. Isaacs, W. Xu, G. Merz, S. Hillier, L. Rohan et al., Digallate Dimers of (-)-Epigallocatechin Gallate Inactivate Herpes Simplex Virus, Antimicrobial Agents and Chemotherapy, vol.55, pp.5646-5653, 2011.

K. Ishiuchi, Y. Kosuge, H. Hamagami, M. Ozaki, K. Ishige et al., Chemical constituents isolated from Juncus effusus induce cytotoxicity in HT22 cells, J Nat Med, vol.69, pp.421-426, 2015.

I. M. Jacobson, G. J. Dore, G. R. Foster, M. W. Fried, M. Radu et al., Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial, Lancet, vol.384, issue.14, pp.60494-60497, 2014.

I. M. Jacobson, J. G. Mchutchison, G. Dusheiko, A. M. Di-bisceglie, K. R. Reddy et al., Telaprevir for previously untreated chronic hepatitis C virus infection, N Engl J Med, vol.364, pp.2405-2416, 2011.

H. L. Janssen, H. W. Reesink, E. J. Lawitz, S. Zeuzem, M. Rodriguez-torres et al., , p.241

S. Kauppinen, A. A. Levin, M. R. Hodges, S. Kauppinen, A. A. Levin et al., Treatment of HCV Infection by Targeting MicroRNA, New England Journal of Medicine, vol.368, pp.1685-1694, 2013.

A. C. Jardim, Z. Igloi, J. F. Shimizu, V. A. Santos, L. G. Felippe et al., Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro, Antiviral Research, vol.115, pp.39-47, 2015.

J. Jeon, J. H. Kim, C. K. Lee, C. H. Oh, and H. J. Song, The Antimicrobial Activity of (-)Epigallocatehin-3-Gallate and Green Tea Extracts against Pseudomonas aeruginosa and Escherichia coli Isolated from Skin Wounds, Annals of Dermatology, vol.26, 2014.

M. Jeong, H. Ko, H. Jeon, G. Sung, S. Park et al., Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells, Oncotarget, 2016.

J. Jiang, W. Cun, X. Wu, Q. Shi, H. Tang et al., Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate, Journal of Virology, vol.86, pp.7256-7267, 2012.

J. Jiang, X. Wu, H. Tang, and G. Luo, Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors, PLoS One, vol.8, 2013.

W. Jilg, Adult use of hepatitis A vaccine in developed countries, Vaccine, vol.11, issue.1, pp.6-8, 1993.

F. Jin, G. V. Matthews, and A. E. Grulich, Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review, Sex Health, 2016.

V. Jirasko, R. Montserret, N. Appel, A. Janvier, L. Eustachi et al., Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly, Journal of Biological Chemistry, vol.283, pp.28546-28562, 2008.

V. Jirasko, R. Montserret, J. Y. Lee, J. Gouttenoire, D. Moradpour et al., Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly, PLoS Pathogens, vol.6, 2010.

D. M. Jones, A. H. Patel, P. Targett-adams, and J. Mclauchlan, The Hepatitis C Virus NS4B Protein Can trans-Complement Viral RNA Replication and Modulates Production of Infectious Virus, Journal of Virology, vol.83, pp.2163-2177, 2009.

A. Kohlway, N. Pirakitikulr, F. N. Barrera, O. Potapova, D. M. Engelman et al., Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain, J Virol, vol.88, pp.628-642, 2014.

S. Koklu, I. Koksal, U. S. Akarca, A. Balkan, R. Guner et al., Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: results of Turkish early access program, Ann Hepatol, vol.16, pp.71-76, 2017.

A. A. Kolykhalov, E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone et al., Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA, Science, vol.277, pp.570-574, 1997.

D. Komes, A. Bel??ak-cvitanovi?, D. Hor?i?, G. Rusak, S. Liki? et al., Phenolic composition and antioxidant properties of some traditionally used medicinal plants affected by the extraction time and hydrolysis, Phytochemical Analysis, vol.22, pp.172-180, 2011.

L. Kong, E. Giang, T. Nieusma, R. U. Kadam, K. E. Cogburn et al., Hepatitis C Virus E2 Envelope Glycoprotein Core Structure, Science, vol.342, pp.1090-1094, 2013.

I. Kotta-loizou, N. Vassilaki, G. Pissas, A. Kakkanas, L. Bakiri et al., Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site, Journal of General Virology, vol.94, pp.1528-1534, 2013.

G. Koutsoudakis, A. Kaul, E. Steinmann, S. Kallis, V. Lohmann et al., Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, pp.5308-5320, 2006.

T. Krey, J. Alayer, C. M. Kikuti, A. Saulnier, L. Damier-piolle et al., The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule, PLoS Pathogens, vol.6, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00460826

P. Krishnan, J. Beyer, N. Mistry, G. Koev, T. Reisch et al., In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A, Antimicrob Agents Chemother, vol.59, pp.979-987, 2015.

D. J. Kroll, H. S. Shaw, and N. H. Oberlies, Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies, Integr Cancer Ther, vol.6, pp.110-119, 2007.

S. Krugman, J. P. Giles, and J. Hammond, Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection, JAMA, vol.200, pp.365-373, 1967.

H. Ksouri, P. Balanant, J. Tadie, G. Heraud, I. Abboud et al., Impact of morbidity and mortality conferences on analysis of mortality and critical events in intensive care practice, Am J Crit Care, vol.19, pp.135-145, 2010.

H. Ksouri, F. Mellouli, and M. Bejaoui, , 2008.

, Arch Inst Pasteur Tunis, vol.85, pp.91-105

R. Ksouri, W. Megdiche, H. Falleh, N. Trabelsi, M. Boulaaba et al., Influence of biological, environmental and technical factors on phenolic content and antioxidant activities of Tunisian halophytes, C R Biol, vol.331, pp.865-873, 2008.

H. Kumada, S. Mochida, F. Suzuki, K. Chayama, Y. Karino et al., Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies, J Gastroenterol Hepatol, vol.31, pp.1674-1683, 2016.

K. Kumthip and N. Maneekarn, The role of HCV proteins on treatment outcomes, Virol J, vol.12, p.217, 2015.

Y. Kushima, T. Wakita, and M. Hijikata, A Disulfide-Bonded Dimer of the Core Protein of Hepatitis C Virus Is Important for Virus-Like Particle Production, Journal of Virology, vol.84, pp.9118-9127, 2010.

K. Lacek, K. Vercauteren, K. Grzyb, M. Naddeo, L. Verhoye et al., Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice, J Hepatol, vol.57, pp.17-23, 2012.

A. M. Lam, C. Espiritu, S. Bansal, H. M. Micolochick-steuer, C. Niu et al., Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus, Antimicrob Agents Chemother, vol.56, pp.3359-3368, 2012.

D. Lamarre, P. C. Anderson, M. Bailey, P. Beaulieu, G. Bolger et al., , p.246

S. H. Kawai, G. Kukolj, S. H. Kawai, G. Kukolj, L. Lagace et al., An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus, Nature, vol.426, pp.186-189, 2003.

K. Lan, Y. Wang, W. Lee, K. Lan, S. Tseng et al., Multiple effects of honokiol on the life cycle of hepatitis C virus, Liver International, vol.32, pp.989-997, 2012.

R. E. Lanford, E. S. Hildebrandt-eriksen, A. Petri, R. Persson, M. Lindow et al., Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection, Science, vol.327, pp.198-201, 2010.

C. M. Lange, D. Miki, H. Ochi, H. Nischalke, J. Bojunga et al., Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development, PLoS One, vol.8, 2013.

C. M. Lange and S. Zeuzem, Perspectives and challenges of interferon-free therapy for chronic hepatitis C, Journal of hepatology, vol.58, pp.583-592, 2013.

O. Launay and D. Floret, Vaccination contre l'hépatite B. médecine/sciences 31, pp.551-558, 2015.

D. Lavanchy, Evolving epidemiology of hepatitis C virus, Clinical Microbiology and Infection, vol.17, pp.107-115, 2011.

M. Lavie, S. Sarrazin, R. Montserret, V. Descamps, T. F. Baumert et al., Identification of Conserved Residues in Hepatitis C Virus Envelope Glycoprotein E2 That Modulate Virus Dependence on CD81 and SRB1 Entry Factors, Journal of Virology, vol.88, pp.10584-10597, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02104532

E. Lawitz, E. Gane, B. Pearlman, E. Tam, W. Ghesquiere et al., Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial, Lancet, vol.385, issue.14, pp.61795-61800, 2015.

E. Lawitz, G. Matusow, E. Dejesus, E. M. Yoshida, F. Felizarta et al., Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection, 2015.

,

E. Lawitz, M. Sulkowski, I. Jacobson, W. K. Kraft, B. Maliakkal et al., Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics, Antiviral Res, vol.99, 2013.

E. J. Lawitz, H. Dvory-sobol, B. P. Doehle, A. S. Worth, J. Mcnally et al., Clinical Resistance to Velpatasvir (GS5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein, Antimicrob Agents Chemother, vol.60, pp.5368-5378, 2016.

C. A. Lazaro, M. Chang, W. Tang, J. Campbell, D. G. Sullivan et al., Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes, The American Journal of Pathology, vol.170, pp.478-489, 2007.

C. Lee, Daclatasvir: potential role in hepatitis C. Drug Design, Development and Therapy 1223, 2013.

M. Lee, P. Maliakal, L. Chen, X. Meng, F. Y. Bondoc et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, Cancer Epidemiol Biomarkers Prev, vol.11, pp.1025-1032, 2002.

S. R. Lee, K. W. Kardos, E. Schiff, C. A. Berne, K. Mounzer et al., Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid, J Virol Methods, vol.172, pp.27-31, 2011.

G. Leroux-roels, E. Depla, F. Hulstaert, L. Tobback, S. Dincq et al., A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers, Vaccine, vol.22, pp.3080-3086, 2004.

C. A. Lesburg, M. B. Cable, E. Ferrari, Z. Hong, A. F. Mannarino et al., Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site, Nat Struct Biol, vol.6, pp.937-943, 1999.

K. Li, E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon et al., Immune evasion by hepatitis C virus NS3/4A proteasemediated cleavage of the Toll-like receptor 3 adaptor protein TRIF, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.2992-2997, 2005.

M. Li, J. Li, Q. Gu, J. An, L. Cao et al., EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation, Oncol Rep, vol.35, pp.2339-2347, 2016.

Q. Li, Y. Zhang, S. Chiu, Z. Hu, K. Lan et al., Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle, PLoS Pathog, vol.10, 2014.

S. Li, T. Hattori, and E. N. Kodama, Epigallocatechin gallate inhibits the HIV reverse transcription step, Antivir Chem Chemother, vol.21, pp.239-243, 2011.
DOI : 10.3851/imp1774
URL : http://journals.sagepub.com/doi/pdf/10.3851/IMP1774

Y. Liang, H. Ye, C. B. Kang, and H. S. Yoon, Domain 2 of Nonstructural Protein 5A (NS5A) of Hepatitis C Virus Is Natively Unfolded ?, Biochemistry, vol.46, pp.11550-11558, 2007.

L. Lin, M. Wang, T. Tseng, J. Sung, and T. Tsai, Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution, J Agric Food Chem, vol.55, pp.1517-1524, 2007.
DOI : 10.1021/jf062816a

L. Lin, C. Chung, W. Hsu, S. Chang, T. Hung et al., Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry, J Hepatol, vol.62, pp.541-548, 2015.
DOI : 10.1016/j.jhep.2014.10.040

B. D. Lindenbach, Virion assembly and release, Curr Top Microbiol Immunol, vol.369, pp.199-218, 2013.
DOI : 10.1007/978-3-642-27340-7_8
URL : http://europepmc.org/articles/pmc3925669?pdf=render

B. D. Lindenbach, M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen et al., Complete replication of hepatitis C virus in cell culture, Science, vol.309, pp.623-626, 2005.

B. D. Lindenbach, B. M. Pragai, R. Montserret, R. K. Beran, A. M. Pyle et al., The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication, Journal of Virology, vol.81, pp.8905-8918, 2007.
DOI : 10.1128/jvi.00937-07
URL : https://jvi.asm.org/content/81/17/8905.full.pdf

M. Lindow and S. Kauppinen, Discovering the first microRNA-targeted drug, J Cell Biol, vol.199, pp.407-412, 2012.
DOI : 10.1083/jcb.201208082
URL : http://jcb.rupress.org/content/199/3/407.full.pdf

J. O. Link, J. G. Taylor, L. Xu, M. Mitchell, H. Guo et al., Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection, J Med Chem, vol.57, pp.2033-2046, 2014.

M. Liu, L. Zhou, P. He, Y. Zhang, J. Zhou et al., Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy, European Journal of Medicinal Chemistry, vol.52, pp.33-43, 2012.
DOI : 10.1016/j.ejmech.2012.03.002

S. Liu, H. Li, L. Chen, L. Yang, L. Li et al., Epigallocatechin-3-gallate inhibition of EpsteinBarr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells, Carcinogenesis, vol.34, pp.627-637, 2013.

S. Liu, X. Wang, Y. Liu, and Y. Cui, PI3K/AKT/mTOR signaling is involved in ()-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells, Am J Chin Med, vol.41, pp.629-642, 2013.

S. Liu, W. Kuo, W. Yang, W. Liu, G. A. Gibson et al., The second extracellular loop dictates Occludin-mediated HCV entry, Virology, vol.407, pp.160-170, 2010.
DOI : 10.1016/j.virol.2010.08.009
URL : https://doi.org/10.1016/j.virol.2010.08.009

N. J. Liverton, S. S. Carroll, J. Dimuzio, C. Fandozzi, D. J. Graham et al., MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease, Antimicrob Agents Chemother, vol.54, pp.305-311, 2010.
DOI : 10.1128/aac.00677-09
URL : https://aac.asm.org/content/54/1/305.full.pdf

A. Lobstein, X. Brenne, E. Feist, N. Metz, B. Weniger et al., Quantitative determination of naphthoquinones of Impatiens species, Phytochem Anal, vol.12, pp.202-205, 2001.
DOI : 10.1002/pca.574

. Lohmann, Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineInducible Protein Kinase PKR by, 1999.

V. Lohmann and R. Bartenschlager, On the History of Hepatitis C Virus Cell Culture Systems: Miniperspective, Journal of Medicinal Chemistry, vol.57, pp.1627-1642, 2014.

V. Lohmann, S. Hoffmann, U. Herian, F. Penin, and R. Bartenschlager, Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture, Journal of Virology, vol.77, pp.3007-3019, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00313699

V. Lohmann, F. Korner, U. Herian, and R. Bartenschlager, Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity, J Virol, vol.71, pp.8416-8428, 1997.

E. Lontok, P. Harrington, A. Howe, T. Kieffer, J. Lennerstrand et al., Hepatitis C virus drug resistance-associated substitutions: State of the art summary, Hepatology, vol.62, pp.1623-1632, 2015.

I. C. Lorenz, J. Marcotrigiano, T. G. Dentzer, and C. M. Rice, Structure of the catalytic domain of the hepatitis C virus NS2-3 protease, Nature, vol.442, pp.831-835, 2006.

S. Lourenco, F. Costa, B. Debarges, T. Andrieu, and A. Cahour, Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by cis-acting RNA elements and trans-acting viral factors, FEBS J, vol.275, pp.4179-4197, 2008.

P. Lozach, A. Amara, B. Bartosch, J. Virelizier, F. Arenzana-seisdedos et al., C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles, J Biol Chem, vol.279, pp.32035-32045, 2004.

P. Lozach, H. Lortat-jacob, A. De-lacroix-de-lavalette, I. Staropoli, S. Foung et al., DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J Biol Chem, vol.278, pp.20358-20366, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01061433

N. T. Lu, C. M. Crespi, N. M. Liu, J. Q. Vu, Y. Ahmadieh et al., A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C, Phytother Res, vol.30, pp.160-168, 2016.

P. Luik, C. Chew, J. Aittoniemi, J. Chang, P. J. Wentworth et al., The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy, Proc Natl Acad Sci U S A, vol.106, pp.12712-12716, 2009.

M. Lundin, H. Lindstrom, C. Gronwall, and M. A. Persson, Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein, J Gen Virol, vol.87, pp.3263-3272, 2006.

M. Lundin, M. Monne, A. Widell, G. Von-heijne, and M. A. Persson, Topology of the membrane-associated hepatitis C virus protein NS4B, J Virol, vol.77, pp.5428-5438, 2003.

J. Lupberger, M. B. Zeisel, F. Xiao, C. Thumann, I. Fofana et al., EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nat Med, vol.17, pp.589-595, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00705829

S. Lyu, J. Rhim, and W. Park, Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro, Arch Pharm Res, vol.28, pp.1293-1301, 2005.

Y. Ma, C. Li, F. Gao, Y. Xu, Z. Jiang et al., Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway, Oncol Rep, vol.31, pp.1343-1349, 2014.

K. Mabe, M. Yamada, I. Oguni, and T. Takahashi, In vitro and in vivo activities of tea catechins against Helicobacter pylori, Antimicrobial agents and chemotherapy, vol.43, pp.1788-1791, 1999.

K. Machida, K. T. Cheng, N. Pavio, V. M. Sung, and M. M. Lai, Hepatitis C Virus E2-CD81 Interaction Induces Hypermutation of the Immunoglobulin Gene in B Cells, Journal of Virology, vol.79, pp.8079-8089, 2005.

C. L. Mack, R. P. Gonzalez-peralta, N. Gupta, D. Leung, M. R. Narkewicz et al., NASPGHAN Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents, Journal of Pediatric Gastroenterology and Nutrition, vol.54, pp.838-855, 2012.

V. Madan and R. Bartenschlager, Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses, vol.7, pp.4461-4481, 2015.

V. Madan, D. Paul, V. Lohmann, and R. Bartenschlager, Inhibition of HCV Replication by Cyclophilin Antagonists Is Linked to Replication Fitness and Occurs by Inhibition of Membranous Web Formation, Gastroenterology, vol.146, pp.1361-1372, 2014.

M. Maeda-yamamoto, N. Suzuki, Y. Sawai, T. Miyase, M. Sano et al., Association of Suppression of Extracellular SignalRegulated Kinase Phosphorylation by Epigallocatechin Gallate with the Reduction of Matrix Metalloproteinase Activities in Human Fibrosarcoma HT1080 Cells, Journal of Agricultural and Food Chemistry, vol.51, pp.1858-1863, 2003.

C. Manach, C. Morand, O. Texier, M. L. Favier, G. Agullo et al., Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin, J Nutr, vol.125, pp.1911-1922, 1995.

C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, Polyphenols: food sources and bioavailability, Am J Clin Nutr, vol.79, 2004.
DOI : 10.1093/ajcn/79.5.727
URL : https://academic.oup.com/ajcn/article-pdf/79/5/727/23713284/znu00504000727.pdf

C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, Polyphenols: food sources and bioavailability, Am J Clin Nutr, vol.79, pp.727-747, 2004.
DOI : 10.1093/ajcn/79.5.727
URL : https://academic.oup.com/ajcn/article-pdf/79/5/727/23713284/znu00504000727.pdf

C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, 2005.

, Am J Clin Nutr, vol.81, pp.230-242

C. Mancone, C. Steindler, L. Santangelo, G. Simonte, C. Vlassi et al., Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins, Gut, vol.60, pp.378-386, 2011.
DOI : 10.1136/gut.2010.211292
URL : https://hal.archives-ouvertes.fr/pasteur-00980167

A. Marchese, E. Coppo, A. Sobolev, D. Rossi, L. Mannina et al., Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis), Food Research International, 2014.

B. Marques, A. I. Lillebø, E. Pereira, and A. C. Duarte, Mercury cycling and sequestration in salt marshes sediments: An ecosystem service provided by Juncus maritimus and Scirpus maritimus, Environmental Pollution, vol.159, pp.1869-1876, 2011.
DOI : 10.1016/j.envpol.2011.03.036

D. N. Martin and S. L. Uprichard, Identification of transferrin receptor 1 as a hepatitis C virus entry factor, Proceedings of the National Academy of Sciences, vol.110, pp.10777-10782, 2013.

D. L. Marzio and J. M. Fenkel, Complementary and alternative medications in hepatitis C infection, World J Hepatol, vol.6, pp.9-16, 2014.
DOI : 10.4254/wjh.v6.i1.9
URL : http://europepmc.org/articles/pmc3953807?pdf=render

T. Masaki, R. Suzuki, K. Murakami, H. Aizaki, K. Ishii et al., Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles, Journal of Virology, vol.82, pp.7964-7976, 2008.

S. C. Matheny and J. E. Kingery, Hepatitis A, Am Fam Physician, vol.86, pp.1027-1061, 2012.

M. Matsuda, R. Suzuki, C. Kataoka, K. Watashi, H. Aizaki et al., Alternative endocytosis pathway for productive entry of hepatitis C virus, Journal of General Virology, vol.95, pp.2658-2667, 2014.

H. Matsumoto, Y. Nakamura, H. Iida, K. Ito, and H. Ohguro, Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues, Experimental Eye Research, vol.83, pp.348-356, 2006.

H. Matsumoto, E. Takenami, K. Iwasaki-kurashige, T. Osada, T. Katsumura et al., Effects of blackcurrant anthocyanin intake on peripheral muscle circulation during typing work in humans, European Journal of Applied Physiology, vol.94, pp.36-45, 2005.

Y. Matsumoto, T. Matsuura, H. Aoyagi, M. Matsuda, S. S. Hmwe et al., Antiviral activity of glycyrrhizin against hepatitis C virus in vitro, PLoS One, vol.8, 2013.

T. Matsumura, T. Kato, N. Sugiyama, M. Tasaka-fujita, A. Murayama et al., 25-Hydroxyvitamin D3 suppresses hepatitis C virus production, Hepatology, vol.56, pp.1231-1239, 2012.
DOI : 10.1002/hep.25763
URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.25763

M. C. Matuschek, W. H. Hendriks, T. K. Mcghie, and G. W. Reynolds, The jejunum is the main site of absorption for anthocyanins in mice, J Nutr Biochem, vol.17, pp.31-36, 2006.

P. Maupas, A. Goudeau, P. Coursaget, J. Drucker, and P. Bagros, Immunisation against hepatitis B in man, Lancet, vol.1, pp.1367-1370, 1976.
DOI : 10.1016/s0140-6736(76)93023-3

K. Mccaffrey, H. Gouklani, I. Boo, P. Poumbourios, and H. E. Drummer, The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity, Journal of General Virology, vol.92, pp.112-121, 2011.

T. F. Mccaul, K. N. Tsiquaye, G. Tovey, C. Hames, and A. J. Zuckerman, Application of electron microscopy to the study of structural changes in the liver in non-A, non-B hepatitis, J Virol Methods, vol.4, pp.87-106, 1982.

D. R. Mcgivern, T. Masaki, W. Lovell, C. Hamlett, S. Saalau-bethell et al., Protease Inhibitors Block Multiple Functions of the NS3/4A ProteaseHelicase during the Hepatitis C Virus Life Cycle, J Virol, vol.89, pp.5362-5370, 2015.

J. G. Mchutchison, S. C. Gordon, E. R. Schiff, M. L. Shiffman, W. M. Lee et al., Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group, N Engl J Med, vol.339, pp.1485-1492, 1998.

D. L. Mckay and J. B. Blumberg, The role of tea in human health: an update, J Am Coll Nutr, vol.21, pp.1-13, 2002.

J. Mclauchlan, M. K. Lemberg, G. Hope, and B. Martoglio, Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets, EMBO J, vol.21, pp.3980-3988, 2002.

L. K. Mcmullan, A. Grakoui, M. J. Evans, K. Mihalik, M. Puig et al., Evidence for a functional RNA element in the hepatitis C virus core gene, Proceedings of the National Academy of Sciences, vol.104, pp.2879-2884, 2007.

C. J. Mee, J. Grove, H. J. Harris, K. Hu, P. Balfe et al., Effect of cell polarization on hepatitis C virus entry, J Virol, vol.82, pp.461-470, 2008.

A. Meeprasert, S. Hannongbua, and T. Rungrotmongkol, Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus, J Chem Inf Model, vol.54, pp.1208-1217, 2014.
DOI : 10.1021/ci400605a

L. Meertens, C. Bertaux, and T. Dragic, Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, pp.11571-11578, 2006.
DOI : 10.1128/jvi.01717-06
URL : http://europepmc.org/articles/pmc1642584?pdf=render

M. C. Mendes-correa, A. A. Barone, and R. J. Gianini, Risk factors associated with hepatitis C among patients co-infected with human immunodeficiency virus: a case-control study, Am J Trop Med Hyg, vol.72, pp.762-767, 2005.

X. Meng, S. Sang, N. Zhu, H. Lu, S. Sheng et al., Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats, Chem Res Toxicol, vol.15, pp.1042-1050, 2002.

R. M. Menon, P. S. Badri, T. Wang, A. R. Polepally, J. Zha et al., Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir, J Hepatol, vol.63, pp.20-29, 2015.

N. Menzel, W. Fischl, K. Hueging, D. Bankwitz, A. Frentzen et al., MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles, PLoS Pathogens, vol.8, 2012.

D. F. Mercer, D. E. Schiller, J. F. Elliott, D. N. Douglas, C. Hao et al., Hepatitis C virus replication in mice with chimeric human livers, Nature medicine, vol.7, pp.927-933, 2001.

P. Meuleman, J. Hesselgesser, M. Paulson, T. Vanwolleghem, I. Desombere et al., Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo, Hepatology, vol.48, pp.1761-1768, 2008.
DOI : 10.1002/hep.22547

J. Meunier, J. M. Gottwein, M. Houghton, R. S. Russell, S. U. Emerson et al., Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus, J Infect Dis, vol.204, pp.1186-1190, 2011.
DOI : 10.1093/infdis/jir511
URL : https://academic.oup.com/jid/article-pdf/204/8/1186/18065640/jir511.pdf

, Virology, vol.78, pp.13278-13284

D. Moradpour, V. Brass, and F. Penin, Function follows form: The structure of the N-terminal domain of HCV NS5A, Hepatology, vol.42, pp.732-735, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00313680

D. Moradpour and F. Penin, Hepatitis C Virus: From Molecular Virology to Antiviral Therapy, pp.113-142, 2013.

D. Moradpour, F. Penin, and C. M. Rice, Replication of hepatitis C virus, Nature Reviews Microbiology, vol.5, pp.453-463, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00313684

K. Morikawa, C. M. Lange, J. Gouttenoire, E. Meylan, V. Brass et al., Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus: HCV NS3-4A, Journal of Viral Hepatitis, vol.18, pp.305-315, 2011.

G. A. Moscato, G. Giannelli, B. Grandi, D. Pieri, O. Marsi et al., Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C, Intervirology, vol.54, pp.61-65, 2011.

W. Mullen, G. Borges, M. E. Lean, S. A. Roberts, and A. Crozier, Identification of metabolites in human plasma and urine after consumption of a polyphenol-rich juice drink, J Agric Food Chem, vol.58, pp.2586-2595, 2010.

V. D. Muller, R. O. Soares, N. N. Santos-junior, A. C. Trabuco, A. C. Cintra et al., Phospholipase A2 Isolated from the Venom of Crotalus durissus terrificus Inactivates Dengue virus and Other Enveloped Viruses by Disrupting the Viral Envelope, PLoS ONE, vol.9, 2014.

C. L. Murray, C. T. Jones, C. M. Rice, and S. Naggie, Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis, Nature Reviews Microbiology, vol.6, pp.154-161, 2008.

S. Naggie and A. J. Muir, Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs, Annu Rev Med, 2016.

Y. Nahmias, M. Casali, L. Barbe, F. Berthiaume, and M. L. Yarmush, Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles 257 in primary ratin primary rat and human hepatocytes, Hepatology, vol.43, pp.257-265, 2006.

Y. Nahmias, J. Goldwasser, M. Casali, D. Van-poll, T. Wakita et al., Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin, Hepatology, vol.47, pp.1437-1445, 2008.

H. Nakabayashi, K. Taketa, K. Miyano, T. Yamane, and J. Sato, Growth of human hepatoma cells lines with differentiated functions in chemically defined medium, Cancer Res, vol.42, pp.3858-3863, 1982.

M. Nakayama, K. Suzuki, M. Toda, S. Okubo, Y. Hara et al., Inhibition of the infectivity of influenza virus by tea polyphenols, Antiviral Res, vol.21, pp.289-299, 1993.

C. L. Nance and W. T. Shearer, Is green tea good for HIV-1 infection?, Journal of allergy and clinical immunology, vol.112, pp.851-853, 2003.

P. Neddermann, M. Quintavalle, C. Di-pietro, A. Clementi, M. Cerretani et al., Reduction of Hepatitis C Virus NS5A Hyperphosphorylation by Selective Inhibition of Cellular Kinases Activates Viral RNA Replication in Cell Culture, Journal of Virology, vol.78, pp.13306-13314, 2004.

P. K. Nelson, B. M. Mathers, B. Cowie, H. Hagan, D. Des-jarlais et al., Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews, Lancet, vol.378, pp.571-583, 2011.

A. U. Neumann, N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley et al., Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science, vol.282, pp.103-107, 1998.

X. Ni and H. Wang, Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD), Am J Transl Res, vol.8, pp.1073-1081, 2016.

S. U. Nielsen, M. F. Bassendine, A. D. Burt, C. Martin, W. Pumeechockchai et al., Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients, J Virol, vol.80, pp.2418-2428, 2006.

L. J. Nohynek, H. Alakomi, M. P. Kähkönen, M. Heinonen, I. M. Helander et al., Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens, Nutrition and cancer, vol.54, pp.18-32, 2006.

O. O'brien, R. J. Wong, and P. C. , Amyloid Precursor Protein Processing and Alzheimer's Disease, Annual Review of Neuroscience, vol.34, pp.185-204, 2011.

V. Oehler, A. Filipe, R. Montserret, D. Da-costa, G. Brown et al., Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase, J Virol, vol.86, pp.7818-7828, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00965776

K. Okamoto, Y. Mori, Y. Komoda, T. Okamoto, M. Okochi et al., Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation, J Virol, vol.82, pp.8349-8361, 2008.

D. L. Ollis, P. Brick, R. Hamlin, N. G. Xuong, and T. A. Steitz, Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP, Nature, vol.313, pp.762-766, 1985.

D. B. Olsen, M. Davies, L. Handt, K. Koeplinger, N. R. Zhang et al., Sustained Viral Response in a Hepatitis C Virus-Infected Chimpanzee via a Combination of Direct-Acting Antiviral Agents, Antimicrobial Agents and Chemotherapy, vol.55, pp.937-939, 2011.

S. Ouwerkerk-mahadevan, J. Snoeys, M. Peeters, M. Beumont-mauviel, and A. Simion, Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir, Clin Pharmacokinet, vol.55, pp.197-208, 2016.

D. M. Owen, H. Huang, J. Ye, and M. Gale, Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor, Virology, vol.394, pp.99-108, 2009.

J. Paeshuyse, A. Kaul, E. De-clercq, B. Rosenwirth, J. Dumont et al., The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro, Hepatology, vol.43, pp.761-770, 2006.

M. F. Palomares-jerez, H. Nemesio, and J. Villalain, Interaction with membranes of the full C-terminal domain of protein NS4B from hepatitis C virus, Biochim Biophys Acta, vol.1818, pp.2536-2549, 2012.

J. Pang, J. Pang, K. Zhao, J. Wang, Z. Ma et al., Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro, Journal of Zhejiang University SCIENCE B, vol.15, pp.533-539, 2014.

C. Pasquinelli, F. Mcphee, T. Eley, C. Villegas, K. Sandy et al., Single-and multipleascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C, Antimicrob Agents Chemother, vol.56, pp.1838-1844, 2012.

K. Patidar, A. Deshmukh, S. Bandaru, C. Lakkaraju, A. Girdhar et al., Virtual Screening Approaches in Identification of Bioactive Compounds Akin to Delphinidin as Potential HER2 Inhibitors for the Treatment of Breast Cancer, Asian Pac J Cancer Prev, vol.17, pp.2291-2295, 2016.

D. Paul, S. Hoppe, G. Saher, J. Krijnse-locker, and R. Bartenschlager, Morphological and Biochemical Characterization of the Membranous Hepatitis C Virus Replication Compartment, Journal of Virology, vol.87, pp.10612-10627, 2013.

J. Pawlotsky, Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens, Gastroenterology, vol.151, pp.70-86, 2016.

J. Pawlotsky, New Hepatitis C Virus (HCV) Drugs and the Hope for a Cure: Concepts in Anti-HCV Drug Development, Seminars in Liver Disease, vol.34, pp.22-029, 2014.

J. Pawlotsky, NS5A inhibitors in the treatment of hepatitis C, Journal of hepatology, vol.59, pp.375-382, 2013.

J. Pawlotsky, Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus, Hepatology, vol.53, pp.1742-1751, 2011.

J. Pawlotsky, A. Aghemo, and D. Back, EASL recommendations on treatment of hepatitis C 2015, J hepatol, vol.63, pp.199-236, 2015.

J. Pawlotsky, H. Dahari, A. U. Neumann, C. Hezode, G. Germanidis et al., Antiviral action of ribavirin in chronic hepatitis C, Gastroenterology, vol.126, pp.703-714, 2004.

T. Pearson, L. D. Shultz, D. Miller, M. King, J. Laning et al., Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment, Clin Exp Immunol, vol.154, pp.270-284, 2008.

V. Pène, C. Hernandez, C. Vauloup-fellous, J. Garaud-aunis, and A. R. Rosenberg, Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment, Journal of Viral Hepatitis, vol.16, pp.705-715, 2009.

F. Penin, C. Combet, G. Germanidis, P. Frainais, G. Deleage et al., Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment, Journal of Virology, vol.75, pp.5703-5710, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00313708

F. Penin, J. Dubuisson, F. A. Rey, D. Moradpour, and J. Pawlotsky, Structural biology of hepatitis C virus, Hepatology, vol.39, pp.5-19, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00313003

J. Perez-jimenez, J. Hubert, L. Hooper, A. Cassidy, C. Manach et al., Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review, American Journal of Clinical Nutrition, vol.92, pp.801-809, 2010.

J. F. Perz, G. L. Armstrong, L. A. Farrington, Y. J. Hutin, and B. P. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, Journal of Hepatology, vol.45, pp.529-538, 2006.

L. S. Pessoa, L. L. Vidal, E. C. Costa, . Da, C. M. Abreu et al., Development of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisions, Genet Mol Biol, vol.39, pp.358-364, 2016.

T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis et al., Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proc Natl Acad Sci U S A, vol.103, pp.7408-7413, 2006.

T. Pietschmann, V. Lohmann, A. Kaul, N. Krieger, G. Rinck et al., Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture, Journal of Virology, vol.76, pp.4008-4021, 2002.

T. Pietschmann, V. Lohmann, G. Rutter, K. Kurpanek, and R. Bartenschlager, Characterization of cell lines carrying self-replicating hepatitis C virus RNAs, J Virol, vol.75, pp.1252-1264, 2001.

P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi et al., Binding of hepatitis C virus to CD81, Science, vol.282, pp.938-941, 1998.

T. Pilot-matias, R. Tripathi, D. Cohen, I. Gaultier, T. Dekhtyar et al., In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450, Antimicrob Agents Chemother, vol.59, pp.988-997, 2015.

E. Piver, A. Boyer, J. Gaillard, A. Bull, E. Beaumont et al., Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture, Gut, 2016.

A. Ploss, M. J. Evans, V. A. Gaysinskaya, M. Panis, H. You et al., Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, vol.457, pp.882-886, 2009.

A. Ploss, S. R. Khetani, C. T. Jones, A. J. Syder, K. Trehan et al., Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures, Proceedings of the National Academy of Sciences, vol.107, pp.3141-3145, 2010.

S. Pohlmann, J. Zhang, F. Baribaud, Z. Chen, G. J. Leslie et al., Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR, J Virol, vol.77, pp.4070-4080, 2003.
DOI : 10.1128/jvi.77.7.4070-4080.2003
URL : https://jvi.asm.org/content/jvi/77/7/4070.full.pdf

S. J. Polyak, P. Ferenci, and J. Pawlotsky, Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection, Hepatology, vol.57, pp.1262-1271, 2013.

S. J. Polyak, C. Morishima, V. Lohmann, S. Pal, D. Y. Lee et al., Identification of hepatoprotective flavonolignans from silymarin, Proceedings of the National Academy of Sciences, vol.107, pp.5995-5999, 2010.
DOI : 10.1073/pnas.0914009107
URL : http://www.pnas.org/content/107/13/5995.full.pdf

S. J. Polyak, N. H. Oberlies, E. Pécheur, H. Dahari, P. Ferenci et al., Silymarin for HCV infection, Antiviral Therapy, vol.18, pp.141-147, 2013.
DOI : 10.3851/imp2402
URL : http://europepmc.org/articles/pmc4076489?pdf=render

F. Poordad, J. Mccone, B. R. Bacon, S. Bruno, M. P. Manns et al., Boceprevir for Untreated Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.364, pp.1195-1206, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00867494

C. Popescu, N. Callens, D. Trinel, P. Roingeard, D. Moradpour et al., NS2 Protein of Hepatitis C Virus Interacts with Structural and Non-Structural Proteins towards Virus Assembly, PLoS Pathogens, vol.7, 2011.

C. Popescu, L. Riva, O. Vlaicu, R. Farhat, Y. Rouillé et al., Hepatitis C Virus Life Cycle and Lipid Metabolism, Biology, vol.3, pp.892-921, 2014.
DOI : 10.3390/biology3040892
URL : https://www.mdpi.com/2079-7737/3/4/892/pdf

N. Popovych, J. R. Brender, R. Soong, S. Vivekanandan, K. Hartman et al., Site Specific Interaction of the Polyphenol EGCG with the SEVI Amyloid Precursor Peptide PAP(248-286), The Journal of Physical Chemistry B, vol.116, pp.3650-3658, 2012.

J. J. Pouliot, M. Thomson, M. Xie, J. Horton, J. Johnson et al., Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein, Antimicrob Agents Chemother, vol.59, pp.6539-6550, 2015.

T. Poynard, P. Bedossa, M. Chevallier, P. Mathurin, C. Lemonnier et al., A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group, N Engl J Med, vol.332, pp.1457-1462, 1995.

T. Poynard, P. Bedossa, and P. Opolon, Natural history of liver fibrosis progression in patients with chronic hepatitis C. The obsvirc, matavir, clinivir and dosvric groups, Lancet, vol.349, pp.825-832, 1997.

J. Prentoe, T. B. Jensen, P. Meuleman, S. B. Serre, T. K. Scheel et al., Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization, J Virol, vol.85, pp.2224-2234, 2011.

A. M. Prince, An antigen detected in the blood during the incubation period of serum hepatitis, Proc Natl Acad Sci U S A, vol.60, pp.814-821, 1968.

W. Pumeechockchai, D. Bevitt, K. Agarwal, T. Petropoulou, B. C. Langer et al., Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody, J Med Virol, vol.68, pp.335-342, 2002.

P. R-raboisson, H. De-kock, A. Rosenquist, M. Nilsson, L. Salvador-oden et al., Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350, Bioorg Med Chem Lett, vol.18, pp.4853-4858, 2008.

R. Radhakrishnan, H. Kulhari, D. Pooja, S. Gudem, S. Bhargava et al., Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer, Chemistry and Physics of Lipids, vol.198, pp.51-60, 2016.

S. Ramirez, Y. Li, S. B. Jensen, J. Pedersen, J. M. Gottwein et al., Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors, Hepatology, vol.59, pp.395-407, 2014.

S. Ramos, Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways, Molecular Nutrition & Food Research, vol.52, pp.507-526, 2008.
DOI : 10.1002/mnfr.200700326
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/mnfr.200700326

K. Rashed, M. Sahuc, G. Deloison, N. Calland, P. Brodin et al., Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro, Journal of Functional Foods, vol.11, pp.185-191, 2014.

H. Rasoolijazi, M. T. Joghataie, M. Roghani, and M. Nobakht, The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis, Iran Biomed J, vol.11, pp.237-243, 2007.

S. Reiss, I. Rebhan, P. Backes, I. Romero-brey, H. Erfle et al., Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment, Cell Host & Microbe, vol.9, pp.32-45, 2011.

K. Rembeck and M. Lagging, Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection, Pharmacogenomics, vol.16, pp.1179-1188, 2015.

C. Rendeiro, J. D. Guerreiro, C. M. Williams, and J. P. Spencer, Flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects, Proc Nutr Soc, vol.71, pp.246-262, 2012.

D. Rey, P. Muret, and L. Piroth, Optimum combination therapy regimens for HIV/HCV infection, Expert Rev Anti Infect Ther, vol.14, pp.299-309, 2016.
DOI : 10.1586/14787210.2016.1147952

W. C. Reygaert, The antimicrobial possibilities of green tea, Frontiers in Microbiology, vol.5, 2014.

J. A. Rhim, E. P. Sandgren, R. D. Palmiter, and R. L. Brinster, Complete reconstitution of mouse liver with xenogeneic hepatocytes, Proceedings of the National Academy of Sciences, vol.92, pp.4942-4946, 1995.

H. Ribeiro, C. M. Almeida, C. Magalhaes, A. A. Bordalo, and A. P. Mucha, Salt marsh sediment characteristics as key regulators on the efficiency of hydrocarbons bioremediation by Juncus maritimus rhizospheric bacterial community, Environ Sci Pollut Res Int, vol.22, pp.450-462, 2015.

H. Ribeiro, A. P. Mucha, C. M. Almeida, and A. A. Bordalo, Potential of phytoremediation for the removal of petroleum hydrocarbons in contaminated salt marsh sediments, J Environ Manage, vol.137, pp.10-15, 2014.

H. Ribeiro, A. P. Mucha, C. M. Almeida, and A. A. Bordalo, Bacterial community response to petroleum contamination and nutrient addition in sediments from a temperate salt marsh, Sci Total Environ, vol.458, pp.568-576, 2013.

R. M. Ribeiro, H. Li, S. Wang, M. B. Stoddard, G. H. Learn et al., Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate, PLoS Pathogens, vol.8, 2012.

A. Rigotti, H. E. Miettinen, and M. Krieger, The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues, Endocrine Reviews, vol.24, pp.357-387, 2003.

E. A. Roberts and L. Yeung, Maternal-infant transmission of hepatitis C virus infection, Hepatology, vol.36, pp.106-113, 2002.

R. Roccasecca, H. Ansuini, A. Vitelli, A. Meola, E. Scarselli et al., Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2, Journal of Virology, vol.77, pp.1856-1867, 2003.

P. Roelandt, S. Obeid, J. Paeshuyse, J. Vanhove, A. Van-lommel et al., Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus, Journal of hepatology, vol.57, pp.246-251, 2012.

C. Roh and S. Jo, (?)-Epigallocatechin gallate inhibits hepatitis C virus (HCV) viral protein NS5B, Talanta, vol.85, pp.2639-2642, 2011.

I. Romero-brey, A. Merz, A. Chiramel, J. Lee, P. Chlanda et al., Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication, PLoS Pathogens, vol.8, 2012.

A. Rosenquist, B. Samuelsson, P. Johansson, M. D. Cummings, O. Lenz et al., Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor, J Med Chem, vol.57, pp.1673-1693, 2014.

Y. Rouille, F. Helle, D. Delgrange, P. Roingeard, C. Voisset et al., Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus, Journal of Virology, vol.80, pp.2832-2841, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00105500

J. Roussel, A. Pillez, C. Montpellier, G. Duverlie, A. Cahour et al., Characterization of the expression of the hepatitis C virus F protein, J Gen Virol, vol.84, pp.1751-1759, 2003.

B. J. Sainz, N. Barretto, D. N. Martin, N. Hiraga, M. Imamura et al., Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nat Med, vol.18, pp.281-285, 2012.

I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama et al., Hepatitis C virus infection is associated with the development of hepatocellular carcinoma, Proceedings of the National Academy of Sciences, vol.87, pp.6547-6549, 1990.

R. Sahli, C. Riviere, M. E. Sahuc, S. Abderrazak, J. Samaillie et al., A new inhibitor of hepatitis C virus replication from Juncus maritimus, a Tunisian extremophile plant, Planta Med, vol.81, 2016.

M. Sanford, Simeprevir: a review of its use in patients with chronic hepatitis C virus infection, Drugs, vol.75, pp.183-196, 2015.

. Santolini, medical virology, vol.46, pp.43-47

R. E. Schwartz, K. Trehan, L. Andrus, T. P. Sheahan, A. Ploss et al., Modeling hepatitis C virus infection using human induced pluripotent stem cells, Proceedings of the National Academy of Sciences, vol.109, pp.2544-2548, 2012.

P. M. Scola, L. Sun, A. X. Wang, J. Chen, N. Sin et al., The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection, J Med Chem, vol.57, pp.1730-1752, 2014.

L. Seeff, Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study, Hepatology, vol.33, pp.455-463, 2001.

M. J. Selby, E. Glazer, F. Masiarz, and M. Houghton, Complex processing and protein:protein interactions in the E2:NS2 region of HCV, Virology, vol.204, pp.114-122, 1994.

H. Sendi, M. Mehrab-mohseni, D. M. Foureau, S. Ghosh, T. L. Walling et al., miR-122 decreases HCV entry into hepatocytes through binding to the 3? UTR of OCLN mRNA, Liver International, vol.35, pp.1315-1323, 2015.

N. R. Sharma, G. Mateu, M. Dreux, A. Grakoui, F. Cosset et al., Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion, Journal of Biological Chemistry, vol.286, pp.30361-30376, 2011.
DOI : 10.1074/jbc.m111.263350
URL : http://www.jbc.org/content/286/35/30361.full.pdf

G. Shi, T. Ando, R. Suzuki, M. Matsuda, K. Nakashima et al., Involvement of the 3' Untranslated Region in Encapsidation of the Hepatitis C Virus, PLOS Pathogens, vol.12, 2016.

Q. Shi, J. Jiang, and G. Luo, Syndecan-1 Serves as the Major Receptor for Attachment of Hepatitis C Virus to the Surfaces of Hepatocytes, Journal of Virology, vol.87, pp.6866-6875, 2013.

W. Shi, I. T. Freitas, C. Zhu, W. Zheng, W. W. Hall et al., Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants, PLoS ONE, vol.7, 2012.
DOI : 10.1371/journal.pone.0041997
URL : https://doi.org/10.1371/journal.pone.0041997

T. Shimoike, C. Koyama, K. Murakami, R. Suzuki, Y. Matsuura et al., Down-regulation of the internal ribosome entry site (IRES)mediated translation of the hepatitis C virus: critical role of binding of the stemloop IIId domain of IRES and the viral core protein, Virology, vol.345, pp.434-445, 2006.

M. Shindo, A. M. Di-bisceglie, L. Cheung, J. W. Shih, K. Cristiano et al., Decrease in serum hepatitis C viral RNA during alphainterferon therapy for chronic hepatitis C, Ann Intern Med, vol.115, pp.700-704, 1991.

S. Shivkumar, R. Peeling, Y. Jafari, L. Joseph, and N. P. Pai, Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and metaanalysis, Annals of internal medicine, vol.157, pp.558-566, 2012.

A. Shrivastava, S. K. Manna, R. Ray, and B. B. Aggarwal, Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors, J Virol, vol.72, pp.9722-9728, 1998.

B. N. Singh, S. Shankar, and R. K. Srivastava, Green tea catechin, epigallocatechin-3gallate (EGCG): Mechanisms, perspectives and clinical applications, Biochemical Pharmacology, vol.82, pp.1807-1821, 2011.
DOI : 10.1016/j.bcp.2011.07.093
URL : http://europepmc.org/articles/pmc4082721?pdf=render

S. J. Skidmore and F. Tadros, Hepatitis A virus, Lancet, vol.2, pp.848-849, 1976.

D. B. Smith, J. Bukh, C. Kuiken, A. S. Muerhoff, C. M. Rice et al., Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource, Hepatology, vol.59, pp.318-327, 2014.
DOI : 10.1002/hep.26744
URL : http://europepmc.org/articles/pmc4063340?pdf=render

J. Song, K. Lee, and B. Seong, Antiviral effect of catechins in green tea on influenza virus, Antiviral Research, vol.68, pp.66-74, 2005.

Y. Song, P. Friebe, E. Tzima, C. Junemann, R. Bartenschlager et al., The hepatitis C virus RNA 3'-untranslated region strongly enhances translation directed by the internal ribosome entry site, J Virol, vol.80, pp.11579-11588, 2006.
DOI : 10.1128/jvi.00675-06
URL : https://jvi.asm.org/content/80/23/11579.full.pdf

V. Soriano, E. Poveda, E. Vispo, P. Labarga, N. Rallon et al., Pharmacogenetics of hepatitis C, J Antimicrob Chemother, vol.67, pp.523-529, 2012.
DOI : 10.1093/jac/dkr506
URL : https://academic.oup.com/jac/article-pdf/67/3/523/2377828/dkr506.pdf

K. Spangberg, L. Goobar-larsson, M. Wahren-herlenius, and S. Schwartz, The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3' untranslated region, J Hum Virol, vol.2, pp.296-307, 1999.

Z. Stamataki, S. Coates, S. Abrignani, M. Houghton, and J. A. Mckeating, Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains, J Infect Dis, vol.204, pp.811-813, 2011.
DOI : 10.1093/infdis/jir399
URL : https://academic.oup.com/jid/article-pdf/204/5/811/18065740/jir399.pdf

E. Steinmann, C. Brohm, S. Kallis, R. Bartenschlager, and T. Pietschmann, Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles, J Virol, vol.82, pp.7034-7046, 2008.
DOI : 10.1128/jvi.00118-08
URL : https://jvi.asm.org/content/82/14/7034.full.pdf

E. Steinmann, F. Penin, S. Kallis, A. H. Patel, R. Bartenschlager et al., Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions, PLoS Pathogens, vol.3, 2007.
DOI : 10.1371/journal.ppat.0030103
URL : https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.0030103&type=printable

E. Steinmann and T. Pietschmann, Hepatitis C Virus: From Molecular Virology to Antiviral Therapy, pp.17-48, 2013.

E. Steinmann and T. Pietschmann, Hepatitis C Virus P7-A Viroporin Crucial for Virus Assembly and an Emerging Target for Antiviral Therapy, Viruses, vol.2, pp.2078-2095, 2010.
DOI : 10.3390/v2092078
URL : https://www.mdpi.com/1999-4915/2/9/2078/pdf

J. Steinmann, J. Buer, T. Pietschmann, and E. Steinmann, Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea: Antiinfective effects of EGCG, British Journal of Pharmacology, vol.168, pp.1059-1073, 2013.

M. Stone, S. Jia, W. D. Heo, T. Meyer, and K. V. Konan, Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery, J Virol, vol.81, pp.4551-4563, 2007.

. Genève, M. Sulkowski, C. Hezode, J. Gerstoft, J. M. Vierling et al., Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial, Lancet, vol.385, issue.14, pp.61793-61794, 2013.

M. S. Sulkowski, J. J. Eron, D. Wyles, R. Trinh, J. Lalezari et al., Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial, JAMA, vol.313, pp.1223-1231, 2015.

M. S. Sulkowski, D. F. Gardiner, M. Rodriguez-torres, K. R. Reddy, T. Hassanein et al., Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection, New England Journal of Medicine, vol.370, pp.211-221, 2014.
DOI : 10.1056/nejmoa1306218

V. Summa, S. W. Ludmerer, J. A. Mccauley, C. Fandozzi, C. Burlein et al., MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, Antimicrob Agents Chemother, vol.56, pp.4161-4167, 2012.

R. J. Sumpter, Y. Loo, E. Foy, K. Li, M. Yoneyama et al., Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I, J Virol, vol.79, pp.2689-2699, 2005.
DOI : 10.1128/jvi.79.5.2689-2699.2005
URL : https://jvi.asm.org/content/79/5/2689.full.pdf

T. Suzuki, K. Ishii, H. Aizaki, and T. Wakita, Hepatitis C viral life cycle, Advanced Drug Delivery Reviews, vol.59, pp.1200-1212, 2007.
DOI : 10.1016/j.addr.2007.04.014

A. J. Syder, H. Lee, M. B. Zeisel, J. Grove, E. Soulier et al., Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors, J Hepatol, vol.54, pp.48-55, 2011.
DOI : 10.1016/j.jhep.2010.06.024

P. Targett-adams, S. Boulant, and J. Mclauchlan, Visualization of DoubleStranded RNA in Cells Supporting Hepatitis C Virus RNA Replication, Journal of Virology, vol.82, pp.2182-2195, 2008.

L. E. Taylor, J. A. Foont, A. K. Delong, A. Wurcel, B. P. Linas et al., The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic, AIDS Patient Care and STDs, vol.28, pp.4-9, 2014.

T. L. Tellinghuisen, K. L. Foss, and J. Treadaway, Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein, PLoS Pathogens, vol.4, 2008.

T. L. Tellinghuisen, K. L. Foss, J. C. Treadaway, and C. M. Rice, Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein, Journal of Virology, vol.82, pp.1073-1083, 2008.

T. L. Tellinghuisen, J. Marcotrigiano, A. E. Gorbalenya, and C. M. Rice, The NS5A protein of hepatitis C virus is a zinc metalloprotein, J Biol Chem, vol.279, pp.48576-48587, 2004.

T. L. Tellinghuisen, J. Marcotrigiano, and C. M. Rice, Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase, Nature, vol.435, pp.374-379, 2005.

V. S. Thakur, K. Gupta, and S. Gupta, The chemopreventive and chemotherapeutic potentials of tea polyphenols, Curr Pharm Biotechnol, vol.13, pp.191-199, 2012.

R. Thimme, J. Bukh, H. C. Spangenberg, S. Wieland, J. Pemberton et al., Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease, Proc Natl Acad Sci U S A, vol.99, pp.15661-15668, 2002.
DOI : 10.1073/pnas.202608299
URL : http://www.pnas.org/content/99/24/15661.full.pdf

R. Thimme, D. Oldach, K. Chang, C. Steiger, S. C. Ray et al., Determinants of viral clearance and persistence during acute hepatitis C virus infection, The Journal of experimental medicine, vol.194, pp.1395-1406, 2001.

D. L. Thomas, C. L. Thio, M. P. Martin, Y. Qi, D. Ge et al., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, vol.461, pp.798-801, 2009.

A. J. Thompson and J. G. Mchutchison, Antiviral resistance and specifically targeted therapy for HCV (STAT-C), J Viral Hepat, vol.16, pp.377-387, 2009.
DOI : 10.1111/j.1365-2893.2009.01124.x

A. P. Thrift, H. B. El-serag, and F. Kanwal, Global epidemiology and burden of HCV infection and HCV-related disease, Nat Rev Gastroenterol Hepatol, vol.14, pp.122-132, 2017.

J. M. Timpe, Z. Stamataki, A. Jennings, K. Hu, M. J. Farquhar et al., Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies, Hepatology, vol.47, pp.17-24, 2007.

M. J. Tong, N. S. El-farra, A. R. Reikes, and R. L. Co, Clinical outcomes after transfusion-associated hepatitis C, New England Journal of Medicine, vol.332, pp.1463-1466, 1995.

P. Toniutto, C. Fabris, D. Bitetto, E. Fornasiere, R. Rapetti et al., Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus, Curr Opin Investig Drugs, vol.8, pp.150-158, 2007.

P. L. Tran, S. Kim, H. S. Choi, J. Yoon, and S. Ahn, Epigallocatechin-3gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo, BMC Cancer, vol.10, p.276, 2010.

M. Triyatni, B. Saunier, P. Maruvada, A. R. Davis, L. Ulianich et al., Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry, J Virol, vol.76, pp.9335-9344, 2002.

K. Tsukiyama-kohara, N. Iizuka, M. Kohara, and A. Nomoto, Internal ribosome entry site within hepatitis C virus RNA, Journal of virology, vol.66, pp.1476-1483, 1992.

U. U-ullmann, J. Haller, J. P. Decourt, N. Girault, J. Girault et al., A single ascending dose study of epigallocatechin gallate in healthy volunteers, J Int Med Res, vol.31, pp.88-101, 2003.

S. Urbani, B. Amadei, P. Fisicaro, D. Tola, A. Orlandini et al., Outcome of acute hepatitis C is related to virusspecific CD4 function and maturation of antiviral memory CD8 responses, Hepatology, vol.44, pp.126-139, 2006.

M. Valega, A. I. Lillebo, M. E. Pereira, A. C. Duarte, and M. A. Pardal, Long-term effects of mercury in a salt marsh: hysteresis in the distribution of vegetation following recovery from contamination, Chemosphere, vol.71, pp.765-772, 2008.

G. Van't-slot and H. Humpf, Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model, J Agric Food Chem, vol.57, pp.8041-8048, 2009.

A. Vanzo, U. Vrhovsek, F. Tramer, F. Mattivi, and S. Passamonti, Exceptionally fast uptake and metabolism of cyanidin 3-glucoside by rat kidneys and liver, J Nat Prod, vol.74, pp.1049-1054, 2011.

T. Vausselin, N. Calland, S. Belouzard, V. Descamps, F. Douam et al., The antimalarial ferroquine is an inhibitor of hepatitis C virus, Hepatology, vol.58, pp.86-97, 2013.

T. Vausselin, K. Seron, M. Lavie, A. A. Mesalam, M. Lemasson et al., Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus, J Virol, vol.90, pp.8422-8434, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02060744

F. Ververidis, E. Trantas, C. Douglas, G. Vollmer, G. Kretzschmar et al., Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health, Biotechnology Journal, vol.2, pp.1214-1234, 2007.

G. Vieyres, J. Dubuisson, and T. Pietschmann, Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion, Viruses, vol.6, pp.1149-1187, 2014.

G. Vieyres, X. Thomas, V. Descamps, G. Duverlie, A. H. Patel et al., Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus, Journal of Virology, vol.84, pp.10159-10168, 2010.

S. A. Villano, D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas, Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection, Hepatology, vol.29, pp.908-914, 1999.

C. Voisset, N. Callens, E. Blanchard, A. Op-de-beeck, J. Dubuisson et al., High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I, J Biol Chem, vol.280, pp.7793-7799, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00105456

C. Voisset and J. Dubuisson, Functional hepatitis C virus envelope glycoproteins, Biology of the Cell, vol.96, pp.413-413, 2004.

J. Wagoner, C. Morishima, T. N. Graf, N. H. Oberlies, E. Teissier et al., Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation, PLoS ONE, vol.6, 2011.

J. Wagoner, A. Negash, O. J. Kane, L. E. Martinez, Y. Nahmias et al., Multiple effects of silymarin on the hepatitis C virus lifecycle, Hepatology, vol.51, pp.1912-1921, 2010.

A. Wahid, F. Helle, V. Descamps, G. Duverlie, F. Penin et al., Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein, J Virol, vol.87, pp.1605-1617, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00965769

T. S. Wahyuni, A. Widyawaruyanti, M. I. Lusida, A. Fuad, . Soetjipto et al., Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves, Fitoterapia, vol.99, pp.276-283, 2014.

J. L. Walewski, T. R. Keller, D. D. Stump, and A. D. Branch, Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame, RNA, vol.7, pp.710-721, 2001.

J. M. Walker, D. Klakotskaia, D. Ajit, G. A. Weisman, W. G. Wood et al., Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model, J Alzheimers Dis, vol.44, pp.561-572, 2015.

T. C. Wallace, M. Slavin, and C. L. Frankenfeld, Systematic Review of Anthocyanins and Markers of Cardiovascular Disease, Nutrients, vol.8, 2016.

C. Wang, L. Jia, H. Huang, D. Qiu, L. Valera et al., In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A, Antimicrob Agents Chemother, vol.56, 2012.

C. Wang, S. Y. Le, N. Ali, and A. Siddiqui, An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5'noncoding region, Rna, vol.1, pp.526-537, 1995.

R. Wang, W. Zhou, and X. Jiang, Reaction Kinetics of Degradation and Epimerization of Epigallocatechin Gallate (EGCG) in Aqueous System over a Wide Temperature Range, Journal of Agricultural and Food Chemistry, vol.56, pp.2694-2701, 2008.

Y. Wang, Y. Wang, H. Zhai, Y. Liao, B. Zhang et al., Phenanthrenes from Juncus effusus with anxiolytic and sedative activities, Nat Prod Res, vol.26, pp.1234-1239, 2012.

T. Watanabe, F. Sugauchi, Y. Tanaka, K. Matsuura, H. Yatsuhashi et al., Hepatitis C virus kinetics by administration of pegylated interferon-alpha in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene, Gut, vol.62, pp.1340-1346, 2013.

C. Weber, K. Sliva, C. Von-rhein, B. M. Kümmerer, and B. S. Schnierle, The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection, Antiviral Research, vol.113, pp.1-3, 2015.

F. Wei, S. Liu, X. Liu, Z. Li, B. Li et al., Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B, Eur J Clin Microbiol Infect Dis, vol.32, pp.657-669, 2013.

A. J. Weiner, G. Kuo, D. W. Bradley, F. Bonino, G. Saracco et al., Detection of hepatitis C viral sequences in nonA, non-B hepatitis, Lancet, vol.335, pp.1-3, 1990.

J. Whidby, G. Mateu, H. Scarborough, B. Demeler, A. Grakoui et al., Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain, Journal of Virology, vol.83, pp.11078-11089, 2009.

M. Wiese, F. Berr, M. Lafrenz, H. Porst, and U. Oesen, Low frequency of cirrhosis in a hepatitis C(genotype 1b) single-source outbreak in germany: A 20-year multicenter study, Hepatology, vol.32, pp.91-96, 2000.

T. E. Wiley, M. Mccarthy, L. Breidi, M. Mccarthy, and T. J. Layden, Impact of alcohol on the histological and clinical progression of hepatitis C infection, Hepatology, vol.28, pp.805-809, 1998.

G. Williamson, F. Dionisi, and M. Renouf, Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages, Mol Nutr Food Res, vol.55, pp.864-873, 2011.

M. Williamson, T. Mccormick, C. Nance, and W. Shearer, Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy, Journal of Allergy and Clinical Immunology, vol.118, pp.1369-1374, 2006.

E. M. Wilson, J. Bial, B. Tarlow, G. Bial, B. Jensen et al., Extensive double humanization of both liver and hematopoiesis in FRGN mice, Stem Cell Res, vol.13, pp.404-412, 2014.

B. Wölk, D. Sansonno, H. Kräusslich, F. Dammacco, C. M. Rice et al., Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines, Journal of virology, vol.74, pp.2293-2304, 2000.

, Guidelines for the screening, care and treatment of persons with hepatitis C infection, 2014.

M. Worobey and E. C. Holmes, Evolutionary aspects of recombination in RNA viruses, J Gen Virol, vol.80, pp.2535-2543, 1999.

Y. Wu, Naturally derived anti-hepatitis B virus agents and their mechanism of action, World Journal of Gastroenterology, vol.22, p.188, 2016.

F. Xiao, I. Fofana, L. Heydmann, H. Barth, E. Soulier et al., Hepatitis C Virus CellCell Transmission and Resistance to Direct-Acting Antiviral Agents, PLoS Pathogens, vol.10, 2014.

X. Xiao, Z. Yang, L. Shi, J. Liu, and W. Chen, , 2008.

, Zhongguo Zhong Yao Za Zhi, vol.33, pp.2678-2682

Z. C. Xie, J. I. Riezu-boj, J. J. Lasarte, J. Guillen, J. H. Su et al., Transmission of hepatitis C virus infection to tree shrews, Virology, vol.244, pp.513-520, 1998.

J. Xu, W. Gu, C. Li, X. Li, G. Xing et al., Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha, Journal of Natural Medicines, vol.70, pp.584-591, 2016.

X. Xu, H. Chen, X. Cao, and K. Ben, Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma, Journal of General Virology, vol.88, pp.2504-2512, 2007.

Y. Xu, P. Martinez, K. Séron, G. Luo, F. Allain et al., Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans, Journal of Virology, vol.89, pp.3846-3858, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02104516

Z. Xu, J. Choi, T. S. Yen, W. Lu, A. Strohecker et al., Synthesis of a novel hepatitis C virus protein by ribosomal frameshift, EMBO J, vol.20, pp.3840-3848, 2001.

Y. Yamaguchi, K. Honda, M. Ikigai, H. Hara, Y. Shimamuray-yamaguchi et al., Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1), Antiviral research, vol.53, pp.19-34, 2002.

H. Yang, C. Yang, Y. Wang, G. Rhodes, M. Robinson et al., Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256, Antivir Ther, 2017.

Z. Yang, L. Bai, W. Huang, X. Li, S. Zhao et al., Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis, Fitoterapia, vol.93, pp.47-53, 2014.

N. Yao, P. Reichert, S. S. Taremi, W. W. Prosise, and P. C. Weber, Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase, Structure, vol.7, pp.1353-1363, 1999.

Q. Yi, P. P. Wang, and M. Krahn, Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection, Journal of viral hepatitis, vol.11, pp.166-174, 2004.

G. Yu, K. Lee, L. Gao, and M. M. Lai, Palmitoylation and polymerization of hepatitis C virus NS4B protein, J Virol, vol.80, pp.6013-6023, 2006.

B. Yun, S. Oh, M. Song, Y. Hong, S. Park et al., Inhibitory Effect of Epigallocatechin Gallate on the Virulence of Clostridium difficile PCR Ribotype 027, J Food Sci, vol.80, pp.2925-2931, 2015.

M. B. Zeisel, D. J. Felmlee, and T. F. Baumert, Hepatitis C virus entry, Curr Top Microbiol Immunol, vol.369, pp.87-112, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00850902

M. B. Zeisel, G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum et al., Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.46, pp.1722-1731, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00395706

S. Zeuzem, S. Buggischzeuzem, P. Buggisch, K. Agarwal, P. Marcellin et al., The protease inhibitor, GS9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C, Hepatology, vol.55, pp.749-758, 2012.

S. Zeuzem, S. V. Feinman, J. Rasenack, E. J. Heathcote, M. Lai et al., Peginterferon alfa-2a in patients with chronic hepatitis C, New England Journal of Medicine, vol.343, pp.1666-1672, 2000.

S. Zeuzem, J. Lee, E. Herrmann, J. Fricke, A. U. Neumann et al., Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon ?2a, Gastroenterology, vol.120, pp.1438-1447, 2001.

H. Zhang, K. Rothwangl, A. D. Mesecar, A. Sabahi, L. Rong et al., Lamiridosins, Hepatitis C Virus Entry Inhibitors from Lamium album, Journal of Natural Products, vol.72, pp.2158-2162, 2009.

J. Zhang, D. Nguyen, and K. Hu, Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies, N Am J Med Sci, vol.9, pp.47-54, 2016.

N. Zhang, Z. Liu, Q. Han, J. Chen, S. Lou et al., Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: Comparisons with ribavirin and interferon-? and implications for the development of anti-hepatitis C virus agents, European Journal of Pharmaceutical Sciences, vol.38, pp.332-340, 2009.

C. Zhao, S. Liu, C. Li, L. Yang, and Y. Zu, Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus. Viruses, vol.6, pp.938-950, 2014.

H. Zhao, W. Zhu, L. Jia, X. Sun, G. Chen et al., Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy, Br J Radiol, vol.89, 2016.

M. Zhao, J. Jiang, R. Zheng, H. Pearl, D. Dickinson et al., A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: case study, Inflamm Allergy Drug Targets, vol.11, pp.364-368, 2012.

A. Zheng, F. Yuan, Y. Li, F. Zhu, P. Hou et al., Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus, Journal of Virology, vol.81, pp.12465-12471, 2007.

L. Zhong, J. Hu, W. Shu, B. Gao, and S. Xiong, Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication, Cell Death and Disease, vol.6, 2015.

Y. Zhou, J. Tang, Y. Du, J. Ding, and J. Liu, The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells, Tumour Biol, 2016.

Y. Zhu, W. Ling, H. Guo, F. Song, Q. Ye et al., Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial, Nutrition, Metabolism and Cardiovascular Diseases, vol.23, pp.843-849, 2013.

G. Zuo, Z. Li, L. Chen, and X. Xu, Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease, Antiviral Research, vol.76, pp.86-92, 2007.

*. Liste-des-publications-?-noémie-calland, M. Sahuc, *. , S. Belouzard, V. Pène et al., Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of, Action J Virol, vol.89, pp.10053-10063, 2015.

?. Sahuc, M. E. Sahli, R. Sahpaz, S. Rouillé, Y. Rivière et al., Séron K Dehydrojuncusol extracted from Juncus maritimus is a new inhibitor of HCV replication en preparation ? Séron Karin

K. Rashed, M. E. Sahuc, G. Deloison, N. Calland, P. Brodin et al., Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro, Journal of Functional Foods, vol.11, pp.185-191, 2014.

B. R. Galani, M. E. Sahuc, F. N. Njayou, G. Deloison, P. Mkounga et al., Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro, Front Microbiol, vol.6, p.488, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02104509

B. R. Galani, M. E. Sahuc, G. Sass, F. N. Njayou, C. Loscher et al., Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro, Arch Virol, vol.161, pp.1169-1181, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02104486

R. Sahli, C. Riviere, M. E. Sahuc, S. Abderrazak, J. Samaillie et al., A new inhibitor of hepatitis C virus replication from Juncus maritimus, a Tunisian extremophile plant, Planta Med, vol.81, 2016.

R. Sahli, C. Rivière, C. Neut, J. Bero, M. E. Sahuc et al., An ecological approach to discover new bioactive extracts and products: The case of extremophile plants, Journal of Pharmacy and Pharmacology, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02104464

?. Bamba, . Bordage, . Sahuc, C. Samaillie, . Neut et al., Antiviral and antibacterial effects of 16 plants used in Ivorian traditional medicine, Planta Med, vol.82, 2016.